| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Synthetic Biology | 37 | 2024 | 185 | 10.810 |
Why?
|
| Schistosoma mansoni | 19 | 2021 | 156 | 7.670 |
Why?
|
| Escherichia coli | 63 | 2024 | 4219 | 7.530 |
Why?
|
| Anti-Bacterial Agents | 59 | 2024 | 7408 | 7.330 |
Why?
|
| Genetic Engineering | 35 | 2022 | 933 | 5.930 |
Why?
|
| Occupational Exposure | 55 | 2020 | 1809 | 5.710 |
Why?
|
| Gene Regulatory Networks | 44 | 2024 | 1741 | 5.190 |
Why?
|
| Bacteria | 31 | 2023 | 2199 | 4.990 |
Why?
|
| Chemical Industry | 33 | 2018 | 115 | 4.170 |
Why?
|
| Helminth Proteins | 10 | 2021 | 172 | 4.130 |
Why?
|
| Drug Resistance, Bacterial | 15 | 2022 | 1055 | 3.230 |
Why?
|
| Styrene | 7 | 2020 | 24 | 3.160 |
Why?
|
| Planarians | 10 | 2024 | 55 | 2.910 |
Why?
|
| Systems Biology | 15 | 2020 | 482 | 2.870 |
Why?
|
| Occupational Diseases | 33 | 2020 | 1486 | 2.800 |
Why?
|
| Microbial Viability | 14 | 2021 | 238 | 2.770 |
Why?
|
| Schistosomiasis mansoni | 7 | 2020 | 94 | 2.770 |
Why?
|
| Models, Genetic | 31 | 2016 | 3442 | 2.410 |
Why?
|
| Dioxins | 10 | 2016 | 92 | 2.140 |
Why?
|
| Biosensing Techniques | 9 | 2024 | 677 | 2.130 |
Why?
|
| Bacterial Physiological Phenomena | 7 | 2020 | 119 | 2.070 |
Why?
|
| Drug Discovery | 8 | 2023 | 1057 | 2.040 |
Why?
|
| Microbial Sensitivity Tests | 19 | 2023 | 1949 | 1.990 |
Why?
|
| Schistosoma | 4 | 2023 | 17 | 1.870 |
Why?
|
| Gene Expression Regulation, Bacterial | 20 | 2020 | 1130 | 1.860 |
Why?
|
| Saccharomyces cerevisiae | 16 | 2024 | 2698 | 1.840 |
Why?
|
| Chlorophenols | 8 | 2012 | 16 | 1.770 |
Why?
|
| Gene Expression Regulation | 36 | 2023 | 11903 | 1.660 |
Why?
|
| Escherichia coli Proteins | 16 | 2022 | 1066 | 1.590 |
Why?
|
| Transcription, Genetic | 27 | 2024 | 7593 | 1.590 |
Why?
|
| Acrylonitrile | 12 | 2012 | 20 | 1.580 |
Why?
|
| Biofilms | 10 | 2024 | 621 | 1.540 |
Why?
|
| Drug Resistance, Microbial | 6 | 2014 | 856 | 1.510 |
Why?
|
| Gene Expression Regulation, Fungal | 7 | 2024 | 499 | 1.460 |
Why?
|
| Postural Balance | 14 | 2006 | 617 | 1.410 |
Why?
|
| Carcinogens | 13 | 2018 | 449 | 1.390 |
Why?
|
| Genes, Synthetic | 7 | 2019 | 88 | 1.380 |
Why?
|
| Bacterial Infections | 8 | 2018 | 1403 | 1.340 |
Why?
|
| Ampicillin | 6 | 2022 | 141 | 1.320 |
Why?
|
| Leukemia | 8 | 2015 | 1520 | 1.310 |
Why?
|
| Posture | 15 | 2017 | 953 | 1.300 |
Why?
|
| Genetic Techniques | 4 | 2020 | 428 | 1.280 |
Why?
|
| Anthelmintics | 4 | 2023 | 82 | 1.270 |
Why?
|
| Escherichia coli Infections | 7 | 2021 | 523 | 1.270 |
Why?
|
| Animals | 164 | 2024 | 167963 | 1.250 |
Why?
|
| Genome, Bacterial | 8 | 2022 | 770 | 1.250 |
Why?
|
| Accidents, Occupational | 4 | 2024 | 249 | 1.240 |
Why?
|
| Diagnostic Techniques and Procedures | 2 | 2020 | 220 | 1.240 |
Why?
|
| Schistosomiasis | 5 | 2024 | 64 | 1.230 |
Why?
|
| Plasmids | 10 | 2022 | 2275 | 1.230 |
Why?
|
| DNA, Bacterial | 8 | 2018 | 1456 | 1.230 |
Why?
|
| Pluripotent Stem Cells | 7 | 2017 | 792 | 1.210 |
Why?
|
| Pathology, Molecular | 3 | 2020 | 329 | 1.200 |
Why?
|
| Platyhelminths | 2 | 2018 | 12 | 1.190 |
Why?
|
| Bioengineering | 4 | 2012 | 96 | 1.190 |
Why?
|
| Protein Biosynthesis | 7 | 2021 | 2105 | 1.180 |
Why?
|
| Stem Cells | 10 | 2020 | 3523 | 1.160 |
Why?
|
| Stochastic Processes | 23 | 2016 | 354 | 1.160 |
Why?
|
| Computational Biology | 16 | 2020 | 3505 | 1.150 |
Why?
|
| Containment of Biohazards | 2 | 2018 | 37 | 1.140 |
Why?
|
| Benzofurans | 4 | 2009 | 142 | 1.140 |
Why?
|
| Norfloxacin | 5 | 2015 | 24 | 1.130 |
Why?
|
| Kanamycin | 4 | 2015 | 64 | 1.120 |
Why?
|
| Formaldehyde | 9 | 2010 | 358 | 1.100 |
Why?
|
| Carbon | 4 | 2022 | 669 | 1.070 |
Why?
|
| Parasites | 3 | 2022 | 161 | 1.070 |
Why?
|
| RNA | 12 | 2023 | 2722 | 1.030 |
Why?
|
| Benzene | 6 | 2015 | 106 | 1.030 |
Why?
|
| Drug Tolerance | 3 | 2019 | 369 | 1.020 |
Why?
|
| Reactive Oxygen Species | 9 | 2022 | 2138 | 1.010 |
Why?
|
| Bacteriophages | 3 | 2015 | 372 | 1.000 |
Why?
|
| Gram-Negative Bacteria | 2 | 2019 | 272 | 0.970 |
Why?
|
| Cell Physiological Phenomena | 3 | 2018 | 150 | 0.970 |
Why?
|
| Adult Stem Cells | 3 | 2017 | 221 | 0.940 |
Why?
|
| Oxidative Stress | 10 | 2017 | 3106 | 0.940 |
Why?
|
| Bacterial Proteins | 13 | 2022 | 3826 | 0.940 |
Why?
|
| Host-Parasite Interactions | 2 | 2017 | 301 | 0.930 |
Why?
|
| Peritonitis | 2 | 2017 | 369 | 0.930 |
Why?
|
| Models, Biological | 29 | 2018 | 9467 | 0.920 |
Why?
|
| Toluene 2,4-Diisocyanate | 3 | 2017 | 10 | 0.920 |
Why?
|
| Communicable Diseases | 2 | 2023 | 878 | 0.900 |
Why?
|
| Lactococcus lactis | 3 | 2018 | 29 | 0.900 |
Why?
|
| Antimicrobial Cationic Peptides | 2 | 2016 | 354 | 0.890 |
Why?
|
| Riboswitch | 2 | 2020 | 12 | 0.880 |
Why?
|
| RNA Interference | 12 | 2020 | 2846 | 0.870 |
Why?
|
| DNA | 10 | 2022 | 7233 | 0.850 |
Why?
|
| Guanidines | 1 | 2023 | 193 | 0.850 |
Why?
|
| Citric Acid Cycle | 4 | 2021 | 230 | 0.850 |
Why?
|
| Muscular Dystrophies | 6 | 2017 | 389 | 0.850 |
Why?
|
| Nucleic Acids | 3 | 2023 | 188 | 0.840 |
Why?
|
| DNA Damage | 10 | 2022 | 2442 | 0.830 |
Why?
|
| Genomics | 12 | 2023 | 5794 | 0.820 |
Why?
|
| Candida albicans | 2 | 2017 | 374 | 0.820 |
Why?
|
| Genes, Bacterial | 6 | 2021 | 1071 | 0.820 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 4 | 2023 | 586 | 0.810 |
Why?
|
| Amdinocillin | 1 | 2022 | 7 | 0.810 |
Why?
|
| Feces | 8 | 2022 | 1455 | 0.810 |
Why?
|
| RNA Editing | 2 | 2023 | 151 | 0.810 |
Why?
|
| Promoter Regions, Genetic | 14 | 2017 | 5785 | 0.800 |
Why?
|
| Cause of Death | 24 | 2018 | 3725 | 0.800 |
Why?
|
| Pentachlorophenol | 5 | 2009 | 10 | 0.800 |
Why?
|
| Humans | 339 | 2024 | 760621 | 0.800 |
Why?
|
| Chromatin | 5 | 2024 | 2938 | 0.790 |
Why?
|
| Signal Transduction | 25 | 2024 | 23376 | 0.790 |
Why?
|
| Pheromones | 1 | 2022 | 93 | 0.780 |
Why?
|
| Endodeoxyribonucleases | 2 | 2020 | 164 | 0.780 |
Why?
|
| Gene Expression | 10 | 2020 | 7588 | 0.780 |
Why?
|
| Transcriptional Activation | 6 | 2015 | 1755 | 0.780 |
Why?
|
| Staining and Labeling | 2 | 2020 | 1089 | 0.780 |
Why?
|
| Green Fluorescent Proteins | 8 | 2018 | 2057 | 0.770 |
Why?
|
| Salmonella typhimurium | 2 | 2013 | 344 | 0.750 |
Why?
|
| Enterococcus faecium | 1 | 2022 | 101 | 0.750 |
Why?
|
| Caenorhabditis elegans | 10 | 2022 | 1444 | 0.750 |
Why?
|
| Air Pollutants, Occupational | 7 | 2017 | 407 | 0.740 |
Why?
|
| Genome | 5 | 2018 | 1739 | 0.740 |
Why?
|
| Paper | 2 | 2018 | 85 | 0.740 |
Why?
|
| DNA Transposable Elements | 2 | 2023 | 756 | 0.740 |
Why?
|
| Basic Reproduction Number | 1 | 2020 | 35 | 0.740 |
Why?
|
| Germ Cells | 4 | 2017 | 635 | 0.730 |
Why?
|
| Penicillin-Binding Proteins | 1 | 2022 | 148 | 0.730 |
Why?
|
| RNA Processing, Post-Transcriptional | 3 | 2012 | 415 | 0.730 |
Why?
|
| Anilides | 1 | 2023 | 409 | 0.730 |
Why?
|
| Polychlorinated Biphenyls | 5 | 2014 | 235 | 0.720 |
Why?
|
| Transcription Factors | 18 | 2024 | 12103 | 0.720 |
Why?
|
| Operon | 2 | 2021 | 370 | 0.720 |
Why?
|
| Aminoglycosides | 4 | 2021 | 163 | 0.720 |
Why?
|
| Blood | 2 | 2020 | 586 | 0.720 |
Why?
|
| Engineering | 2 | 2023 | 56 | 0.710 |
Why?
|
| Gene Expression Regulation, Developmental | 8 | 2017 | 3604 | 0.710 |
Why?
|
| Eukaryotic Cells | 4 | 2013 | 196 | 0.710 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 1 | 2020 | 126 | 0.700 |
Why?
|
| Accidental Falls | 6 | 2024 | 1056 | 0.700 |
Why?
|
| Quinolones | 5 | 2017 | 377 | 0.700 |
Why?
|
| Oxidation-Reduction | 6 | 2016 | 2222 | 0.680 |
Why?
|
| Life Cycle Stages | 3 | 2021 | 160 | 0.680 |
Why?
|
| Thiadiazoles | 1 | 2020 | 64 | 0.680 |
Why?
|
| Cell Respiration | 2 | 2017 | 202 | 0.680 |
Why?
|
| RNA, Messenger | 17 | 2021 | 12766 | 0.680 |
Why?
|
| Organisms, Genetically Modified | 2 | 2018 | 63 | 0.680 |
Why?
|
| Biosynthetic Pathways | 1 | 2020 | 135 | 0.680 |
Why?
|
| Staphylococcus aureus | 7 | 2023 | 1462 | 0.670 |
Why?
|
| Mice | 68 | 2024 | 81208 | 0.670 |
Why?
|
| Collagen Type VI | 6 | 2017 | 25 | 0.670 |
Why?
|
| Multigene Family | 2 | 2020 | 1077 | 0.670 |
Why?
|
| Protein Engineering | 5 | 2016 | 541 | 0.660 |
Why?
|
| RNA, Bacterial | 6 | 2014 | 385 | 0.660 |
Why?
|
| Micronucleus Tests | 1 | 2018 | 23 | 0.650 |
Why?
|
| Oxygen Consumption | 3 | 2015 | 1843 | 0.640 |
Why?
|
| Musa | 1 | 2018 | 8 | 0.640 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2021 | 330 | 0.640 |
Why?
|
| Biological Evolution | 3 | 2022 | 1074 | 0.630 |
Why?
|
| Micronuclei, Chromosome-Defective | 1 | 2018 | 38 | 0.630 |
Why?
|
| Gram-Positive Bacteria | 1 | 2019 | 178 | 0.620 |
Why?
|
| Gene Expression Profiling | 20 | 2020 | 9411 | 0.620 |
Why?
|
| Cefuroxime | 7 | 1996 | 23 | 0.620 |
Why?
|
| Aging | 15 | 2023 | 8651 | 0.600 |
Why?
|
| Cell-Free System | 2 | 2016 | 341 | 0.600 |
Why?
|
| Polysaccharides, Bacterial | 1 | 2020 | 574 | 0.590 |
Why?
|
| Plasmodium | 1 | 2020 | 247 | 0.590 |
Why?
|
| Metabolome | 4 | 2017 | 982 | 0.580 |
Why?
|
| Hydroxyl Radical | 5 | 2013 | 83 | 0.580 |
Why?
|
| Population Surveillance | 5 | 2017 | 2608 | 0.570 |
Why?
|
| Lymphoma | 3 | 2014 | 1898 | 0.570 |
Why?
|
| Occupational Health | 7 | 2024 | 805 | 0.570 |
Why?
|
| Cell Membrane | 6 | 2021 | 3682 | 0.570 |
Why?
|
| Probiotics | 3 | 2018 | 377 | 0.570 |
Why?
|
| Saccharomyces cerevisiae Proteins | 7 | 2024 | 1854 | 0.570 |
Why?
|
| Opportunistic Infections | 1 | 2020 | 377 | 0.570 |
Why?
|
| Laminin | 5 | 2017 | 405 | 0.560 |
Why?
|
| Neoplasms | 31 | 2021 | 22072 | 0.560 |
Why?
|
| RNA, Untranslated | 2 | 2015 | 459 | 0.560 |
Why?
|
| Enzymes | 1 | 2018 | 261 | 0.550 |
Why?
|
| Mutation | 27 | 2022 | 29932 | 0.550 |
Why?
|
| Carrier State | 1 | 2020 | 525 | 0.550 |
Why?
|
| Cell Differentiation | 24 | 2023 | 11481 | 0.550 |
Why?
|
| Metabolic Networks and Pathways | 3 | 2019 | 789 | 0.550 |
Why?
|
| Communicable Disease Control | 1 | 2023 | 844 | 0.550 |
Why?
|
| Vitellins | 1 | 2016 | 1 | 0.550 |
Why?
|
| Algorithms | 14 | 2023 | 13981 | 0.550 |
Why?
|
| Molecular Biology | 3 | 2021 | 580 | 0.550 |
Why?
|
| Pseudomonas aeruginosa | 2 | 2017 | 1276 | 0.540 |
Why?
|
| Lactobacillus | 3 | 2018 | 204 | 0.540 |
Why?
|
| Proteins | 5 | 2022 | 6029 | 0.540 |
Why?
|
| Cytoplasm | 1 | 2021 | 1516 | 0.540 |
Why?
|
| Biotechnology | 4 | 2018 | 281 | 0.540 |
Why?
|
| Anti-Infective Agents | 2 | 2023 | 981 | 0.530 |
Why?
|
| Repressor Proteins | 12 | 2018 | 2981 | 0.530 |
Why?
|
| Malaria | 3 | 2024 | 1226 | 0.530 |
Why?
|
| Benchmarking | 1 | 2022 | 1044 | 0.520 |
Why?
|
| Esophagus | 2 | 2021 | 1023 | 0.520 |
Why?
|
| Proprioception | 6 | 2003 | 133 | 0.520 |
Why?
|
| Environmental Pollutants | 5 | 2009 | 1266 | 0.510 |
Why?
|
| Epigenomics | 2 | 2021 | 936 | 0.510 |
Why?
|
| Gait | 8 | 2000 | 812 | 0.510 |
Why?
|
| Metagenome | 4 | 2013 | 450 | 0.510 |
Why?
|
| Species Specificity | 9 | 2019 | 2418 | 0.510 |
Why?
|
| Mutagenesis | 5 | 2018 | 1234 | 0.510 |
Why?
|
| Retinal Pigments | 1 | 2015 | 83 | 0.500 |
Why?
|
| Epigenesis, Genetic | 8 | 2020 | 3758 | 0.500 |
Why?
|
| Toxins, Biological | 1 | 2015 | 61 | 0.500 |
Why?
|
| Ocular Physiological Phenomena | 1 | 2015 | 67 | 0.500 |
Why?
|
| Military Personnel | 1 | 2024 | 1244 | 0.500 |
Why?
|
| Vinyl Chloride | 1 | 2014 | 15 | 0.490 |
Why?
|
| Tryptophan Hydroxylase | 1 | 2015 | 94 | 0.490 |
Why?
|
| Embryonic Stem Cells | 8 | 2020 | 1262 | 0.490 |
Why?
|
| Mammals | 6 | 2023 | 1131 | 0.490 |
Why?
|
| Zinc Fingers | 3 | 2015 | 568 | 0.490 |
Why?
|
| RNA, Catalytic | 2 | 2012 | 53 | 0.490 |
Why?
|
| Muscular Dystrophy, Duchenne | 4 | 2022 | 268 | 0.480 |
Why?
|
| MutS DNA Mismatch-Binding Protein | 1 | 2014 | 10 | 0.480 |
Why?
|
| 2,4,5-Trichlorophenoxyacetic Acid | 3 | 2009 | 15 | 0.480 |
Why?
|
| Genome, Viral | 2 | 2020 | 658 | 0.470 |
Why?
|
| Touch | 3 | 2003 | 312 | 0.470 |
Why?
|
| Parasitology | 2 | 2011 | 28 | 0.470 |
Why?
|
| Michigan | 8 | 2015 | 342 | 0.460 |
Why?
|
| Mitochondria | 4 | 2017 | 3600 | 0.460 |
Why?
|
| Chromosome Aberrations | 1 | 2020 | 1764 | 0.460 |
Why?
|
| Polysaccharides | 1 | 2020 | 1016 | 0.460 |
Why?
|
| Stress, Physiological | 4 | 2016 | 1398 | 0.450 |
Why?
|
| Male | 166 | 2024 | 359744 | 0.450 |
Why?
|
| Catalase | 1 | 2014 | 216 | 0.450 |
Why?
|
| Hydrogels | 1 | 2019 | 723 | 0.450 |
Why?
|
| Computer Simulation | 12 | 2017 | 6218 | 0.450 |
Why?
|
| Heart Valve Prosthesis | 19 | 1998 | 1495 | 0.450 |
Why?
|
| Alanine | 2 | 2021 | 606 | 0.440 |
Why?
|
| Gene Dosage | 2 | 2016 | 1218 | 0.440 |
Why?
|
| Female | 158 | 2024 | 391270 | 0.440 |
Why?
|
| Oxygen | 6 | 2017 | 4193 | 0.440 |
Why?
|
| Prokaryotic Cells | 1 | 2013 | 50 | 0.440 |
Why?
|
| Enterocolitis, Pseudomembranous | 1 | 2015 | 265 | 0.440 |
Why?
|
| Reproduction | 6 | 2024 | 646 | 0.430 |
Why?
|
| Respiratory Tract Neoplasms | 3 | 2006 | 57 | 0.430 |
Why?
|
| Melanins | 1 | 2015 | 291 | 0.430 |
Why?
|
| RNA, Viral | 6 | 2023 | 2838 | 0.430 |
Why?
|
| MicroRNAs | 9 | 2022 | 3790 | 0.430 |
Why?
|
| Hematopoietic Stem Cells | 8 | 2024 | 3387 | 0.420 |
Why?
|
| Histones | 4 | 2022 | 2583 | 0.420 |
Why?
|
| Superoxides | 2 | 2013 | 387 | 0.420 |
Why?
|
| Biocompatible Materials | 2 | 2019 | 1689 | 0.420 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2022 | 2919 | 0.420 |
Why?
|
| Silver | 1 | 2013 | 120 | 0.420 |
Why?
|
| Genes, Helminth | 4 | 2020 | 146 | 0.420 |
Why?
|
| Ethosuximide | 3 | 2008 | 9 | 0.420 |
Why?
|
| Cell Culture Techniques | 3 | 2019 | 1664 | 0.410 |
Why?
|
| Antibody Formation | 3 | 2016 | 1400 | 0.410 |
Why?
|
| Single-Cell Analysis | 6 | 2021 | 2380 | 0.410 |
Why?
|
| Vestibule, Labyrinth | 3 | 2001 | 232 | 0.410 |
Why?
|
| Hemangiosarcoma | 1 | 2014 | 216 | 0.400 |
Why?
|
| Feedback, Physiological | 6 | 2021 | 476 | 0.400 |
Why?
|
| Vaccines | 2 | 2021 | 832 | 0.400 |
Why?
|
| Ciprofloxacin | 3 | 2021 | 312 | 0.400 |
Why?
|
| Vibrio cholerae | 1 | 2018 | 793 | 0.400 |
Why?
|
| Peptides | 3 | 2024 | 4354 | 0.390 |
Why?
|
| Pain, Intractable | 3 | 1999 | 132 | 0.390 |
Why?
|
| Apoptosis | 6 | 2017 | 9501 | 0.390 |
Why?
|
| Induced Pluripotent Stem Cells | 8 | 2023 | 1846 | 0.390 |
Why?
|
| Cholera | 1 | 2018 | 747 | 0.390 |
Why?
|
| Diabetic Neuropathies | 3 | 2006 | 406 | 0.390 |
Why?
|
| Microbial Consortia | 2 | 2024 | 33 | 0.390 |
Why?
|
| Inhalation Exposure | 4 | 2019 | 429 | 0.390 |
Why?
|
| Lymphoma, Non-Hodgkin | 6 | 2018 | 1375 | 0.390 |
Why?
|
| Body Patterning | 1 | 2016 | 632 | 0.390 |
Why?
|
| Hydrogen Sulfide | 2 | 2014 | 141 | 0.390 |
Why?
|
| Prodrugs | 5 | 1996 | 259 | 0.380 |
Why?
|
| Phosgene | 1 | 2011 | 2 | 0.380 |
Why?
|
| Regeneration | 3 | 2017 | 1506 | 0.380 |
Why?
|
| Molecular Targeted Therapy | 2 | 2020 | 2803 | 0.380 |
Why?
|
| Vestibular Nerve | 2 | 2002 | 101 | 0.380 |
Why?
|
| Gentamicins | 1 | 2012 | 252 | 0.380 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2013 | 238 | 0.380 |
Why?
|
| Agrochemicals | 2 | 2018 | 10 | 0.380 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2016 | 611 | 0.370 |
Why?
|
| Directed Molecular Evolution | 2 | 2023 | 158 | 0.370 |
Why?
|
| Cells | 3 | 2019 | 164 | 0.370 |
Why?
|
| Laboratories | 1 | 2014 | 462 | 0.370 |
Why?
|
| Mutagenesis, Insertional | 3 | 2023 | 652 | 0.360 |
Why?
|
| Cephalosporins | 3 | 1996 | 204 | 0.360 |
Why?
|
| Gene Transfer, Horizontal | 4 | 2018 | 144 | 0.360 |
Why?
|
| Clostridium Infections | 1 | 2017 | 557 | 0.360 |
Why?
|
| Acinetobacter baumannii | 2 | 2023 | 115 | 0.360 |
Why?
|
| Gene Silencing | 4 | 2018 | 1513 | 0.360 |
Why?
|
| Ribonucleotides | 1 | 2010 | 114 | 0.350 |
Why?
|
| Noise | 2 | 2002 | 280 | 0.350 |
Why?
|
| Mitral Valve | 14 | 1998 | 1486 | 0.350 |
Why?
|
| Drug Delivery Systems | 2 | 2020 | 2221 | 0.350 |
Why?
|
| Neurons, Afferent | 4 | 2002 | 498 | 0.350 |
Why?
|
| Sensory Receptor Cells | 2 | 2008 | 509 | 0.350 |
Why?
|
| Regulatory Elements, Transcriptional | 2 | 2020 | 183 | 0.340 |
Why?
|
| Artificial Intelligence | 2 | 2023 | 2557 | 0.340 |
Why?
|
| Drug Therapy, Combination | 9 | 2020 | 6498 | 0.340 |
Why?
|
| Peptide Hormones | 1 | 2010 | 132 | 0.340 |
Why?
|
| Acrylic Resins | 2 | 2020 | 135 | 0.340 |
Why?
|
| Hydrogen Peroxide | 5 | 2014 | 732 | 0.340 |
Why?
|
| DNA-Binding Proteins | 11 | 2020 | 9585 | 0.330 |
Why?
|
| Mitochondrial Myopathies | 1 | 2009 | 49 | 0.330 |
Why?
|
| Escherichia coli K12 | 1 | 2009 | 34 | 0.330 |
Why?
|
| Luminescent Proteins | 4 | 2018 | 835 | 0.330 |
Why?
|
| Microscopy, Confocal | 2 | 2016 | 1972 | 0.330 |
Why?
|
| History, 20th Century | 8 | 2014 | 2773 | 0.330 |
Why?
|
| Coronary Artery Bypass | 18 | 1999 | 2272 | 0.330 |
Why?
|
| Phenotype | 12 | 2023 | 16546 | 0.330 |
Why?
|
| Tissue Engineering | 1 | 2019 | 1870 | 0.330 |
Why?
|
| Recombinases | 1 | 2009 | 66 | 0.330 |
Why?
|
| Fungal Proteins | 3 | 2017 | 911 | 0.330 |
Why?
|
| Thymidine Kinase | 1 | 2009 | 286 | 0.320 |
Why?
|
| Anticonvulsants | 3 | 2008 | 1879 | 0.320 |
Why?
|
| Fibrinogen | 1 | 2012 | 886 | 0.320 |
Why?
|
| Microbial Interactions | 3 | 2024 | 74 | 0.320 |
Why?
|
| Aminobiphenyl Compounds | 3 | 1999 | 5 | 0.320 |
Why?
|
| Microscopy, Fluorescence | 5 | 2021 | 2651 | 0.320 |
Why?
|
| Vaccines, Synthetic | 1 | 2011 | 617 | 0.320 |
Why?
|
| Drug Design | 3 | 2020 | 1061 | 0.320 |
Why?
|
| Base Sequence | 8 | 2020 | 12446 | 0.310 |
Why?
|
| Biodiversity | 2 | 2015 | 345 | 0.310 |
Why?
|
| Mortality | 6 | 2018 | 2916 | 0.310 |
Why?
|
| Immunologic Factors | 1 | 2017 | 1588 | 0.310 |
Why?
|
| United States | 40 | 2024 | 72461 | 0.310 |
Why?
|
| Pancreatic Neoplasms | 3 | 2014 | 5351 | 0.310 |
Why?
|
| Biomarkers, Pharmacological | 1 | 2009 | 162 | 0.310 |
Why?
|
| Endogenous Retroviruses | 2 | 2022 | 111 | 0.310 |
Why?
|
| Molecular Sequence Data | 11 | 2014 | 17624 | 0.310 |
Why?
|
| Muscle, Skeletal | 9 | 2018 | 4925 | 0.310 |
Why?
|
| Muscle Proteins | 4 | 2020 | 1152 | 0.300 |
Why?
|
| Lifting | 3 | 2007 | 55 | 0.300 |
Why?
|
| Guanosine Tetraphosphate | 1 | 2007 | 11 | 0.300 |
Why?
|
| Anaerobiosis | 2 | 2022 | 139 | 0.300 |
Why?
|
| Employee Performance Appraisal | 2 | 2005 | 86 | 0.300 |
Why?
|
| Bacteriophage T3 | 1 | 2007 | 2 | 0.300 |
Why?
|
| Antifungal Agents | 1 | 2013 | 749 | 0.300 |
Why?
|
| Epidemiologic Studies | 4 | 2018 | 670 | 0.300 |
Why?
|
| Walking | 8 | 2003 | 1189 | 0.300 |
Why?
|
| Genes, Switch | 1 | 2007 | 48 | 0.300 |
Why?
|
| Dengue | 3 | 2022 | 254 | 0.290 |
Why?
|
| Absenteeism | 3 | 2007 | 250 | 0.290 |
Why?
|
| Industry | 4 | 2007 | 361 | 0.290 |
Why?
|
| History, 21st Century | 5 | 2014 | 1575 | 0.290 |
Why?
|
| Graft Rejection | 5 | 2020 | 4426 | 0.290 |
Why?
|
| Morphine | 3 | 1996 | 655 | 0.290 |
Why?
|
| High-Throughput Screening Assays | 3 | 2024 | 944 | 0.290 |
Why?
|
| Risk | 11 | 2018 | 9631 | 0.290 |
Why?
|
| Lung Neoplasms | 13 | 2019 | 13262 | 0.290 |
Why?
|
| Myopathies, Structural, Congenital | 2 | 2018 | 103 | 0.280 |
Why?
|
| Pseudomonas Infections | 1 | 2011 | 623 | 0.280 |
Why?
|
| Disease Models, Animal | 11 | 2023 | 18137 | 0.280 |
Why?
|
| Adult | 91 | 2024 | 219994 | 0.280 |
Why?
|
| In Situ Hybridization | 4 | 2020 | 1900 | 0.280 |
Why?
|
| Drug Interactions | 4 | 2021 | 1428 | 0.280 |
Why?
|
| Epidemiology | 2 | 2007 | 278 | 0.280 |
Why?
|
| Topoisomerase II Inhibitors | 1 | 2007 | 96 | 0.280 |
Why?
|
| Models, Theoretical | 7 | 2019 | 3562 | 0.270 |
Why?
|
| Indoles | 2 | 2012 | 1829 | 0.270 |
Why?
|
| Point-of-Care Systems | 3 | 2021 | 1204 | 0.270 |
Why?
|
| Transportation of Patients | 2 | 2007 | 176 | 0.270 |
Why?
|
| Time Factors | 28 | 2023 | 40165 | 0.270 |
Why?
|
| Sensation Disorders | 2 | 2006 | 160 | 0.270 |
Why?
|
| Viral Proteins | 6 | 2009 | 1802 | 0.270 |
Why?
|
| Glutaral | 1 | 2006 | 76 | 0.260 |
Why?
|
| Logic | 3 | 2019 | 42 | 0.260 |
Why?
|
| Cell Proliferation | 6 | 2019 | 10446 | 0.260 |
Why?
|
| DNA Methylation | 3 | 2016 | 4373 | 0.260 |
Why?
|
| Infant, Low Birth Weight | 1 | 2011 | 859 | 0.260 |
Why?
|
| Carbohydrates | 1 | 2008 | 388 | 0.260 |
Why?
|
| Genes, tat | 1 | 2005 | 15 | 0.260 |
Why?
|
| Bacteriophage T7 | 1 | 2007 | 174 | 0.260 |
Why?
|
| Cell Membrane Permeability | 2 | 2021 | 575 | 0.260 |
Why?
|
| Fluorescent Dyes | 4 | 2024 | 1913 | 0.260 |
Why?
|
| Nanotechnology | 3 | 2024 | 709 | 0.260 |
Why?
|
| Feedback | 5 | 2002 | 791 | 0.260 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 5 | 2014 | 3775 | 0.260 |
Why?
|
| Environmental Exposure | 8 | 2019 | 4412 | 0.250 |
Why?
|
| Antibiotic Prophylaxis | 2 | 2024 | 643 | 0.250 |
Why?
|
| Lab-On-A-Chip Devices | 3 | 2022 | 432 | 0.250 |
Why?
|
| Piracetam | 1 | 2006 | 88 | 0.250 |
Why?
|
| Virulence | 2 | 2020 | 1298 | 0.250 |
Why?
|
| Ecosystem | 3 | 2023 | 485 | 0.250 |
Why?
|
| Hydroxyurea | 3 | 2014 | 282 | 0.250 |
Why?
|
| Vibration | 2 | 2006 | 327 | 0.250 |
Why?
|
| Ribosomal Proteins | 1 | 2007 | 363 | 0.250 |
Why?
|
| Lac Repressors | 3 | 2016 | 15 | 0.250 |
Why?
|
| Gene Knockdown Techniques | 3 | 2021 | 1617 | 0.250 |
Why?
|
| Amikacin | 1 | 2024 | 48 | 0.240 |
Why?
|
| Symbiosis | 2 | 2020 | 291 | 0.240 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2019 | 613 | 0.240 |
Why?
|
| Amino Acid Sequence | 7 | 2018 | 13451 | 0.240 |
Why?
|
| Forecasting | 5 | 2021 | 2932 | 0.240 |
Why?
|
| Brain Neoplasms | 6 | 2014 | 8986 | 0.240 |
Why?
|
| Enzyme Inhibitors | 4 | 2014 | 3726 | 0.240 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2015 | 1394 | 0.240 |
Why?
|
| Genes, Regulator | 2 | 2003 | 374 | 0.240 |
Why?
|
| Gene Library | 3 | 2023 | 1060 | 0.240 |
Why?
|
| Amino Acids | 3 | 2024 | 1714 | 0.230 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 2 | 2017 | 182 | 0.230 |
Why?
|
| New Zealand | 5 | 2018 | 355 | 0.230 |
Why?
|
| Extracellular Matrix | 2 | 2013 | 1726 | 0.230 |
Why?
|
| Genes, Reporter | 5 | 2020 | 1529 | 0.230 |
Why?
|
| Vibrio | 1 | 2004 | 40 | 0.230 |
Why?
|
| Pregnancy Outcome | 3 | 2019 | 2907 | 0.230 |
Why?
|
| Movement | 4 | 2019 | 1474 | 0.230 |
Why?
|
| Ligands | 4 | 2022 | 3276 | 0.230 |
Why?
|
| Polyethylene Glycols | 2 | 2020 | 1189 | 0.230 |
Why?
|
| DNA, Mitochondrial | 1 | 2009 | 858 | 0.230 |
Why?
|
| Folic Acid Antagonists | 1 | 2024 | 75 | 0.230 |
Why?
|
| Bacteriuria | 1 | 2024 | 103 | 0.230 |
Why?
|
| Knee Joint | 7 | 2002 | 1663 | 0.230 |
Why?
|
| Middle Aged | 82 | 2024 | 220352 | 0.230 |
Why?
|
| Polyhydroxyalkanoates | 1 | 2023 | 10 | 0.220 |
Why?
|
| Endonucleases | 2 | 2018 | 370 | 0.220 |
Why?
|
| Locomotion | 2 | 1999 | 387 | 0.220 |
Why?
|
| Incidence | 19 | 2020 | 21392 | 0.220 |
Why?
|
| Risk Management | 1 | 2007 | 558 | 0.220 |
Why?
|
| Hydrazones | 1 | 2023 | 102 | 0.220 |
Why?
|
| Muscle Relaxation | 1 | 2003 | 138 | 0.220 |
Why?
|
| Metabolomics | 3 | 2017 | 1628 | 0.220 |
Why?
|
| Gene Deletion | 4 | 2019 | 2668 | 0.220 |
Why?
|
| Microfluidics | 2 | 2023 | 652 | 0.220 |
Why?
|
| Oxidants | 2 | 2014 | 169 | 0.220 |
Why?
|
| Cat Diseases | 1 | 2022 | 31 | 0.210 |
Why?
|
| Shoes | 1 | 2003 | 94 | 0.210 |
Why?
|
| Registries | 5 | 2014 | 8469 | 0.210 |
Why?
|
| Mitral Valve Insufficiency | 8 | 1998 | 1419 | 0.210 |
Why?
|
| Glucose | 1 | 2015 | 4351 | 0.210 |
Why?
|
| Periodicity | 3 | 2002 | 348 | 0.210 |
Why?
|
| Trans-Activators | 4 | 2016 | 2860 | 0.210 |
Why?
|
| Water Pollutants, Chemical | 2 | 2020 | 354 | 0.210 |
Why?
|
| Models, Statistical | 7 | 2021 | 5075 | 0.210 |
Why?
|
| Peptide Biosynthesis, Nucleic Acid-Independent | 1 | 2022 | 8 | 0.210 |
Why?
|
| Somatosensory Disorders | 1 | 2002 | 49 | 0.210 |
Why?
|
| Aerobiosis | 2 | 2013 | 101 | 0.210 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2019 | 854 | 0.200 |
Why?
|
| Anthozoa | 1 | 2023 | 65 | 0.200 |
Why?
|
| Herbicides | 3 | 2011 | 104 | 0.200 |
Why?
|
| Ligaments, Articular | 3 | 1995 | 300 | 0.200 |
Why?
|
| Mitral Valve Prolapse | 2 | 1994 | 215 | 0.200 |
Why?
|
| Gene Expression Regulation, Viral | 2 | 2005 | 438 | 0.200 |
Why?
|
| Dog Diseases | 1 | 2022 | 141 | 0.200 |
Why?
|
| Genes | 2 | 2003 | 1845 | 0.200 |
Why?
|
| Adenine | 2 | 2019 | 975 | 0.200 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2020 | 2506 | 0.200 |
Why?
|
| Rec A Recombinases | 3 | 2012 | 50 | 0.200 |
Why?
|
| Tryptamines | 1 | 2022 | 93 | 0.200 |
Why?
|
| Adenosine Triphosphate | 3 | 2015 | 1993 | 0.190 |
Why?
|
| Viral Regulatory and Accessory Proteins | 4 | 2005 | 153 | 0.190 |
Why?
|
| Chikungunya virus | 1 | 2022 | 53 | 0.190 |
Why?
|
| Cell Lineage | 7 | 2019 | 2533 | 0.190 |
Why?
|
| Genes, Fungal | 1 | 2003 | 439 | 0.190 |
Why?
|
| Textiles | 1 | 2021 | 45 | 0.190 |
Why?
|
| Carbenicillin | 1 | 2021 | 15 | 0.190 |
Why?
|
| K562 Cells | 2 | 2020 | 640 | 0.190 |
Why?
|
| Linear Models | 5 | 2018 | 5877 | 0.190 |
Why?
|
| Foot | 5 | 2003 | 573 | 0.190 |
Why?
|
| Hypesthesia | 1 | 2002 | 107 | 0.190 |
Why?
|
| Liver Neoplasms | 3 | 2014 | 4319 | 0.190 |
Why?
|
| Sarcoma | 6 | 2018 | 1786 | 0.190 |
Why?
|
| Bioprosthesis | 6 | 1998 | 600 | 0.190 |
Why?
|
| Musculoskeletal System | 1 | 2003 | 181 | 0.190 |
Why?
|
| Ketoglutarate Dehydrogenase Complex | 1 | 2021 | 21 | 0.190 |
Why?
|
| Streptomycin | 1 | 2021 | 70 | 0.190 |
Why?
|
| Aged | 66 | 2017 | 169152 | 0.190 |
Why?
|
| Mice, Inbred C57BL | 10 | 2020 | 22023 | 0.190 |
Why?
|
| Cohort Studies | 26 | 2018 | 41335 | 0.190 |
Why?
|
| Electricity | 1 | 2002 | 182 | 0.190 |
Why?
|
| Tumor Virus Infections | 3 | 2020 | 438 | 0.190 |
Why?
|
| Drug Synergism | 3 | 2021 | 1754 | 0.190 |
Why?
|
| Infant, Premature | 1 | 2011 | 2092 | 0.190 |
Why?
|
| Premature Birth | 2 | 2011 | 1771 | 0.190 |
Why?
|
| Equipment and Supplies | 1 | 2003 | 275 | 0.190 |
Why?
|
| Teratogens | 1 | 2001 | 117 | 0.180 |
Why?
|
| Mathematics | 7 | 2003 | 707 | 0.180 |
Why?
|
| Pseudomonas fluorescens | 1 | 2020 | 21 | 0.180 |
Why?
|
| Regression Analysis | 8 | 2011 | 6360 | 0.180 |
Why?
|
| Ribosomes | 1 | 2004 | 501 | 0.180 |
Why?
|
| Adenosine Deaminase | 1 | 2023 | 251 | 0.180 |
Why?
|
| Dystrophin | 1 | 2022 | 284 | 0.180 |
Why?
|
| Phylogeny | 3 | 2018 | 2775 | 0.180 |
Why?
|
| Teaching | 2 | 2018 | 1169 | 0.180 |
Why?
|
| Nonlinear Dynamics | 6 | 2013 | 494 | 0.180 |
Why?
|
| Microscopy, Atomic Force | 1 | 2021 | 247 | 0.180 |
Why?
|
| Transcutaneous Electric Nerve Stimulation | 1 | 2002 | 170 | 0.180 |
Why?
|
| Phalloidine | 1 | 2020 | 21 | 0.180 |
Why?
|
| Staphylococcal Infections | 4 | 2023 | 1407 | 0.180 |
Why?
|
| Sensation | 1 | 2002 | 331 | 0.180 |
Why?
|
| Cercaria | 1 | 2019 | 1 | 0.180 |
Why?
|
| Labor, Obstetric | 1 | 2023 | 321 | 0.180 |
Why?
|
| Rotifera | 1 | 2019 | 3 | 0.170 |
Why?
|
| Chemokine CXCL9 | 1 | 2020 | 135 | 0.170 |
Why?
|
| Environmental Illness | 1 | 2000 | 34 | 0.170 |
Why?
|
| Sequence Analysis, DNA | 2 | 2021 | 4713 | 0.170 |
Why?
|
| Sequence Deletion | 2 | 2022 | 1493 | 0.170 |
Why?
|
| Asymptomatic Infections | 1 | 2021 | 131 | 0.170 |
Why?
|
| beta-Lactamases | 1 | 2022 | 304 | 0.170 |
Why?
|
| Aged, 80 and over | 35 | 2014 | 58995 | 0.170 |
Why?
|
| Membrane Proteins | 4 | 2017 | 7850 | 0.170 |
Why?
|
| Neurons | 7 | 2015 | 9426 | 0.170 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2024 | 633 | 0.170 |
Why?
|
| Cell Division | 3 | 2014 | 4463 | 0.170 |
Why?
|
| Bacterial Capsules | 1 | 2020 | 242 | 0.170 |
Why?
|
| Adolescent | 36 | 2017 | 87810 | 0.170 |
Why?
|
| Microbiological Techniques | 1 | 2020 | 98 | 0.170 |
Why?
|
| Parthenogenesis | 1 | 2019 | 30 | 0.170 |
Why?
|
| Nerve Net | 5 | 2003 | 2261 | 0.170 |
Why?
|
| Bone Marrow | 2 | 2024 | 2912 | 0.170 |
Why?
|
| Electric Stimulation | 5 | 2003 | 1735 | 0.170 |
Why?
|
| Occupational Medicine | 1 | 2000 | 114 | 0.170 |
Why?
|
| DNA Cleavage | 1 | 2019 | 57 | 0.160 |
Why?
|
| Mechanoreceptors | 2 | 2001 | 187 | 0.160 |
Why?
|
| Models, Neurological | 2 | 1999 | 1758 | 0.160 |
Why?
|
| Polyomavirus | 1 | 2020 | 234 | 0.160 |
Why?
|
| Atlases as Topic | 1 | 2020 | 241 | 0.160 |
Why?
|
| Kinetics | 4 | 2020 | 6377 | 0.160 |
Why?
|
| Haploidy | 1 | 2019 | 133 | 0.160 |
Why?
|
| Solvents | 2 | 1997 | 292 | 0.160 |
Why?
|
| Muscular Diseases | 2 | 2013 | 551 | 0.160 |
Why?
|
| Protein Binding | 4 | 2022 | 9335 | 0.160 |
Why?
|
| Temperature | 6 | 2023 | 2221 | 0.160 |
Why?
|
| Fluoroquinolones | 1 | 2021 | 308 | 0.160 |
Why?
|
| Transgenes | 2 | 2022 | 1006 | 0.160 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2021 | 3735 | 0.160 |
Why?
|
| Thermodynamics | 1 | 2020 | 599 | 0.160 |
Why?
|
| Statistics as Topic | 5 | 2002 | 2362 | 0.160 |
Why?
|
| Colic | 1 | 2018 | 44 | 0.160 |
Why?
|
| HEK293 Cells | 6 | 2021 | 4264 | 0.160 |
Why?
|
| TATA Box | 2 | 2010 | 127 | 0.160 |
Why?
|
| Alternative Splicing | 2 | 2014 | 1091 | 0.160 |
Why?
|
| Information Dissemination | 1 | 2007 | 1131 | 0.160 |
Why?
|
| Dengue Virus | 2 | 2018 | 200 | 0.160 |
Why?
|
| Abnormalities, Drug-Induced | 1 | 2001 | 338 | 0.160 |
Why?
|
| Follow-Up Studies | 23 | 2013 | 39261 | 0.160 |
Why?
|
| Oxidative Phosphorylation | 2 | 2017 | 495 | 0.160 |
Why?
|
| Forced Expiratory Volume | 3 | 2017 | 1809 | 0.150 |
Why?
|
| Alkaloids | 1 | 2019 | 194 | 0.150 |
Why?
|
| Ovum | 1 | 2019 | 187 | 0.150 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 2018 | 2753 | 0.150 |
Why?
|
| Muscle Strength | 2 | 2020 | 619 | 0.150 |
Why?
|
| Leukocyte L1 Antigen Complex | 1 | 2018 | 93 | 0.150 |
Why?
|
| Parkinson Disease | 4 | 2014 | 2859 | 0.150 |
Why?
|
| Arabinose | 2 | 2009 | 30 | 0.150 |
Why?
|
| Palliative Care | 4 | 1998 | 3607 | 0.150 |
Why?
|
| Gastrointestinal Tract | 2 | 2014 | 830 | 0.150 |
Why?
|
| Sulfhydryl Compounds | 1 | 1999 | 299 | 0.150 |
Why?
|
| Home Nursing | 1 | 1998 | 92 | 0.150 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2022 | 678 | 0.150 |
Why?
|
| Polyomavirus Infections | 1 | 2020 | 194 | 0.150 |
Why?
|
| Spinal Cord | 2 | 1999 | 1817 | 0.150 |
Why?
|
| Codon, Terminator | 1 | 2018 | 125 | 0.150 |
Why?
|
| Paneth Cells | 1 | 2018 | 98 | 0.150 |
Why?
|
| Analgesics, Opioid | 4 | 1999 | 3763 | 0.150 |
Why?
|
| RNA, Ribosomal, 16S | 3 | 2018 | 1006 | 0.150 |
Why?
|
| Dextrans | 1 | 2020 | 574 | 0.150 |
Why?
|
| Risk Factors | 24 | 2024 | 74359 | 0.150 |
Why?
|
| 2,4-Dichlorophenoxyacetic Acid | 2 | 2011 | 25 | 0.150 |
Why?
|
| Growth Substances | 1 | 2020 | 768 | 0.150 |
Why?
|
| Tuberous Sclerosis | 1 | 2006 | 1030 | 0.150 |
Why?
|
| Energy Metabolism | 2 | 2021 | 2869 | 0.150 |
Why?
|
| Cells, Cultured | 13 | 2023 | 18957 | 0.150 |
Why?
|
| Small Molecule Libraries | 2 | 2020 | 734 | 0.150 |
Why?
|
| Guidelines as Topic | 3 | 2019 | 1392 | 0.150 |
Why?
|
| DNA, Single-Stranded | 1 | 2019 | 360 | 0.150 |
Why?
|
| Sexual Maturation | 1 | 2019 | 260 | 0.140 |
Why?
|
| Permeability | 1 | 2019 | 719 | 0.140 |
Why?
|
| Ultraviolet Rays | 1 | 2022 | 1078 | 0.140 |
Why?
|
| Population Dynamics | 1 | 2019 | 306 | 0.140 |
Why?
|
| DNA, Superhelical | 1 | 2017 | 51 | 0.140 |
Why?
|
| Leg | 2 | 1995 | 1090 | 0.140 |
Why?
|
| Carcinogens, Environmental | 1 | 1997 | 72 | 0.140 |
Why?
|
| Nanoparticles | 3 | 2020 | 1943 | 0.140 |
Why?
|
| RNA-Binding Proteins | 2 | 2016 | 1894 | 0.140 |
Why?
|
| Cloning, Molecular | 2 | 2020 | 4169 | 0.140 |
Why?
|
| Antimalarials | 1 | 2024 | 906 | 0.140 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2023 | 694 | 0.140 |
Why?
|
| Enzyme Assays | 1 | 2018 | 107 | 0.140 |
Why?
|
| Fluconazole | 1 | 2017 | 155 | 0.140 |
Why?
|
| Immune Evasion | 1 | 2020 | 362 | 0.140 |
Why?
|
| Leukemia, Experimental | 3 | 1983 | 225 | 0.140 |
Why?
|
| RNA, Antisense | 1 | 2017 | 136 | 0.140 |
Why?
|
| Mycobacterium tuberculosis | 2 | 2020 | 1903 | 0.140 |
Why?
|
| Genes, Lethal | 1 | 2017 | 225 | 0.140 |
Why?
|
| DNA, Fungal | 1 | 2018 | 275 | 0.140 |
Why?
|
| Euthanasia | 1 | 1997 | 58 | 0.140 |
Why?
|
| Fluorescent Antibody Technique | 4 | 2020 | 2471 | 0.140 |
Why?
|
| Quorum Sensing | 1 | 2018 | 137 | 0.140 |
Why?
|
| Aortic Aneurysm | 4 | 1997 | 648 | 0.140 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2005 | 1974 | 0.140 |
Why?
|
| Child | 30 | 2020 | 79806 | 0.140 |
Why?
|
| Obstetric Labor Complications | 1 | 2019 | 236 | 0.140 |
Why?
|
| Arthrogryposis | 1 | 2017 | 68 | 0.140 |
Why?
|
| Terminal Care | 4 | 1997 | 1758 | 0.140 |
Why?
|
| Plants | 2 | 2015 | 317 | 0.140 |
Why?
|
| Stomach Ulcer | 1 | 2016 | 123 | 0.140 |
Why?
|
| DNA Replication | 3 | 2014 | 1412 | 0.140 |
Why?
|
| CCAAT-Binding Factor | 1 | 2016 | 21 | 0.140 |
Why?
|
| Immunoassay | 1 | 2020 | 746 | 0.140 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2021 | 601 | 0.140 |
Why?
|
| Spermatogonia | 1 | 2016 | 30 | 0.140 |
Why?
|
| Nasopharyngeal Neoplasms | 2 | 2010 | 286 | 0.140 |
Why?
|
| Antigens, Helminth | 1 | 2016 | 68 | 0.130 |
Why?
|
| Ribonucleases | 1 | 2017 | 277 | 0.130 |
Why?
|
| Cyclins | 1 | 1998 | 593 | 0.130 |
Why?
|
| Fishes | 1 | 1999 | 601 | 0.130 |
Why?
|
| Hydromorphone | 1 | 1996 | 70 | 0.130 |
Why?
|
| Clavulanic Acids | 4 | 1996 | 11 | 0.130 |
Why?
|
| Cross-Linking Reagents | 1 | 2019 | 685 | 0.130 |
Why?
|
| Analgesia, Patient-Controlled | 1 | 1996 | 116 | 0.130 |
Why?
|
| Pregnancy Complications | 2 | 2019 | 2942 | 0.130 |
Why?
|
| Combinatorial Chemistry Techniques | 1 | 2016 | 132 | 0.130 |
Why?
|
| Myography | 1 | 2017 | 111 | 0.130 |
Why?
|
| Flow Cytometry | 5 | 2019 | 5870 | 0.130 |
Why?
|
| RNA, Helminth | 1 | 2016 | 60 | 0.130 |
Why?
|
| Cell Death | 2 | 2014 | 1672 | 0.130 |
Why?
|
| Peristalsis | 1 | 2015 | 59 | 0.130 |
Why?
|
| Receptors, Erythropoietin | 1 | 2016 | 144 | 0.130 |
Why?
|
| Mammary Neoplasms, Experimental | 3 | 2014 | 507 | 0.130 |
Why?
|
| Blood Vessel Prosthesis | 4 | 1996 | 956 | 0.130 |
Why?
|
| Sequence Alignment | 2 | 2010 | 2176 | 0.130 |
Why?
|
| Amoxicillin-Potassium Clavulanate Combination | 4 | 1996 | 33 | 0.130 |
Why?
|
| Longevity | 3 | 2008 | 1050 | 0.130 |
Why?
|
| Ascorbic Acid | 1 | 2019 | 655 | 0.130 |
Why?
|
| Fentanyl | 1 | 1999 | 434 | 0.130 |
Why?
|
| Soft Tissue Neoplasms | 4 | 2009 | 1152 | 0.130 |
Why?
|
| Purines | 1 | 2019 | 605 | 0.130 |
Why?
|
| Embryo, Nonmammalian | 1 | 2019 | 900 | 0.130 |
Why?
|
| Environmental Monitoring | 5 | 2017 | 1441 | 0.130 |
Why?
|
| 5-Hydroxytryptophan | 1 | 2015 | 32 | 0.130 |
Why?
|
| Research | 3 | 2014 | 1974 | 0.130 |
Why?
|
| Skin | 4 | 2023 | 4466 | 0.130 |
Why?
|
| Muscular Dystrophy, Emery-Dreifuss | 1 | 2015 | 21 | 0.130 |
Why?
|
| Texas | 2 | 2008 | 401 | 0.130 |
Why?
|
| Bronchitis | 2 | 1995 | 196 | 0.130 |
Why?
|
| Malaria, Falciparum | 1 | 2024 | 1076 | 0.130 |
Why?
|
| Cytomegalovirus | 1 | 2020 | 755 | 0.130 |
Why?
|
| Motor Skills | 1 | 1998 | 520 | 0.130 |
Why?
|
| Body Height | 2 | 2020 | 1570 | 0.130 |
Why?
|
| Skin Physiological Phenomena | 1 | 1996 | 188 | 0.130 |
Why?
|
| Nucleic Acid Conformation | 2 | 2019 | 899 | 0.130 |
Why?
|
| Hypogravity | 1 | 1995 | 3 | 0.130 |
Why?
|
| Entomoplasmataceae | 1 | 2014 | 1 | 0.120 |
Why?
|
| Confidence Intervals | 8 | 2010 | 2932 | 0.120 |
Why?
|
| Amitriptyline | 1 | 1995 | 112 | 0.120 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2014 | 8515 | 0.120 |
Why?
|
| Spermatogenesis | 1 | 2016 | 257 | 0.120 |
Why?
|
| Rats | 15 | 2022 | 23711 | 0.120 |
Why?
|
| Plectin | 1 | 2014 | 14 | 0.120 |
Why?
|
| Epidermolysis Bullosa Simplex | 1 | 2014 | 12 | 0.120 |
Why?
|
| Survival Rate | 16 | 2008 | 12808 | 0.120 |
Why?
|
| Periaqueductal Gray | 1 | 1995 | 110 | 0.120 |
Why?
|
| Epidermis | 1 | 2018 | 529 | 0.120 |
Why?
|
| Alcohol Dehydrogenase | 1 | 1995 | 113 | 0.120 |
Why?
|
| Oncogene Proteins | 2 | 2016 | 719 | 0.120 |
Why?
|
| Caenorhabditis elegans Proteins | 2 | 2008 | 866 | 0.120 |
Why?
|
| Aortic Valve | 13 | 1998 | 1996 | 0.120 |
Why?
|
| DNA, Viral | 2 | 2020 | 2194 | 0.120 |
Why?
|
| Lymphopenia | 1 | 1997 | 280 | 0.120 |
Why?
|
| Zebrafish | 3 | 2022 | 2997 | 0.120 |
Why?
|
| Green Chemistry Technology | 1 | 2014 | 9 | 0.120 |
Why?
|
| Sequence Analysis, RNA | 3 | 2018 | 2005 | 0.120 |
Why?
|
| Psychomotor Performance | 1 | 2003 | 1878 | 0.120 |
Why?
|
| Amoxicillin | 4 | 1996 | 180 | 0.120 |
Why?
|
| Joints | 2 | 2000 | 321 | 0.120 |
Why?
|
| Biomedical Research | 2 | 2021 | 3426 | 0.120 |
Why?
|
| Amino Acids, Essential | 1 | 2014 | 26 | 0.120 |
Why?
|
| Otitis Media with Effusion | 1 | 1995 | 114 | 0.120 |
Why?
|
| Collagen Type XII | 1 | 2013 | 3 | 0.120 |
Why?
|
| Host Factor 1 Protein | 1 | 2014 | 15 | 0.120 |
Why?
|
| Theophylline | 3 | 1988 | 131 | 0.120 |
Why?
|
| Fibroblasts | 5 | 2023 | 4090 | 0.120 |
Why?
|
| Substrate Specificity | 2 | 2023 | 1792 | 0.120 |
Why?
|
| Urinary Tract Infections | 3 | 2024 | 814 | 0.120 |
Why?
|
| RGS Proteins | 1 | 2014 | 75 | 0.120 |
Why?
|
| Hematopoiesis | 3 | 2024 | 2050 | 0.120 |
Why?
|
| Peer Group | 1 | 2019 | 674 | 0.120 |
Why?
|
| Adaptation, Physiological | 1 | 2021 | 1296 | 0.110 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2016 | 508 | 0.110 |
Why?
|
| Public Health | 2 | 2023 | 2653 | 0.110 |
Why?
|
| Death Certificates | 1 | 2014 | 167 | 0.110 |
Why?
|
| Sodium-Calcium Exchanger | 1 | 2014 | 89 | 0.110 |
Why?
|
| Nurses | 1 | 2003 | 2467 | 0.110 |
Why?
|
| Proviruses | 1 | 2015 | 313 | 0.110 |
Why?
|
| Muscular Dystrophy, Animal | 1 | 2014 | 88 | 0.110 |
Why?
|
| Age Factors | 14 | 2017 | 18416 | 0.110 |
Why?
|
| Cell Line | 5 | 2020 | 15620 | 0.110 |
Why?
|
| Mice, Inbred BALB C | 3 | 2020 | 6216 | 0.110 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2019 | 1347 | 0.110 |
Why?
|
| Perceptual Masking | 2 | 2006 | 90 | 0.110 |
Why?
|
| United States Occupational Safety and Health Administration | 2 | 2023 | 54 | 0.110 |
Why?
|
| Metalloproteins | 1 | 2014 | 101 | 0.110 |
Why?
|
| Epidemiologic Methods | 5 | 2007 | 1343 | 0.110 |
Why?
|
| Mesencephalon | 1 | 1995 | 332 | 0.110 |
Why?
|
| Risk Assessment | 11 | 2019 | 24123 | 0.110 |
Why?
|
| Young Adult | 10 | 2024 | 58741 | 0.110 |
Why?
|
| Klebsiella pneumoniae | 2 | 2024 | 255 | 0.110 |
Why?
|
| Gene Knockout Techniques | 1 | 2016 | 802 | 0.110 |
Why?
|
| Otitis Media | 1 | 1996 | 285 | 0.110 |
Why?
|
| West Virginia | 2 | 2006 | 31 | 0.110 |
Why?
|
| DNA Breaks, Double-Stranded | 2 | 2015 | 607 | 0.110 |
Why?
|
| Miconazole | 1 | 2013 | 9 | 0.110 |
Why?
|
| Cytomegalovirus Infections | 1 | 2020 | 831 | 0.110 |
Why?
|
| Weight Lifting | 1 | 1994 | 126 | 0.110 |
Why?
|
| Environment | 2 | 2017 | 1118 | 0.110 |
Why?
|
| Rhabdoid Tumor | 1 | 1995 | 210 | 0.110 |
Why?
|
| Efficiency, Organizational | 1 | 2018 | 697 | 0.110 |
Why?
|
| Praziquantel | 2 | 2023 | 34 | 0.110 |
Why?
|
| Iron | 3 | 2013 | 1786 | 0.110 |
Why?
|
| Host Specificity | 1 | 2013 | 57 | 0.110 |
Why?
|
| Genomic Instability | 1 | 2017 | 704 | 0.110 |
Why?
|
| Mucous Membrane | 1 | 1996 | 657 | 0.110 |
Why?
|
| Physical Stimulation | 3 | 2003 | 518 | 0.110 |
Why?
|
| Body Mass Index | 4 | 2017 | 12914 | 0.110 |
Why?
|
| Severity of Illness Index | 7 | 2017 | 15840 | 0.110 |
Why?
|
| Bronchial Hyperreactivity | 1 | 1994 | 302 | 0.110 |
Why?
|
| Ureaplasma Infections | 1 | 2012 | 25 | 0.110 |
Why?
|
| Ureaplasma | 1 | 2012 | 60 | 0.110 |
Why?
|
| Erythrocytes | 2 | 2019 | 2415 | 0.110 |
Why?
|
| Allergens | 1 | 2020 | 1402 | 0.110 |
Why?
|
| Pneumonia, Bacterial | 1 | 1996 | 319 | 0.110 |
Why?
|
| Seizures | 1 | 2006 | 2917 | 0.110 |
Why?
|
| Pregnenediones | 1 | 2012 | 29 | 0.110 |
Why?
|
| Maternal Exposure | 2 | 2011 | 1045 | 0.110 |
Why?
|
| Postoperative Complications | 19 | 2020 | 15697 | 0.110 |
Why?
|
| Biomimetics | 1 | 2014 | 173 | 0.100 |
Why?
|
| Homozygote | 1 | 2017 | 1788 | 0.100 |
Why?
|
| Electric Impedance | 1 | 2017 | 755 | 0.100 |
Why?
|
| Helminthiasis | 1 | 2013 | 80 | 0.100 |
Why?
|
| Antioxidants | 2 | 2014 | 1667 | 0.100 |
Why?
|
| Anesthesia, Conduction | 1 | 1996 | 261 | 0.100 |
Why?
|
| Amphotericin B | 1 | 2013 | 142 | 0.100 |
Why?
|
| Child, Preschool | 16 | 2018 | 42063 | 0.100 |
Why?
|
| Sensory Thresholds | 3 | 2002 | 377 | 0.100 |
Why?
|
| Prostatic Neoplasms | 4 | 2007 | 11345 | 0.100 |
Why?
|
| Muscles | 3 | 1996 | 1581 | 0.100 |
Why?
|
| Coronary Disease | 7 | 1995 | 5990 | 0.100 |
Why?
|
| Immunization, Passive | 5 | 1983 | 616 | 0.100 |
Why?
|
| Proportional Hazards Models | 4 | 2018 | 12531 | 0.100 |
Why?
|
| Communication | 2 | 2018 | 3849 | 0.100 |
Why?
|
| Muscle Contraction | 2 | 1995 | 1201 | 0.100 |
Why?
|
| Guanine Nucleotides | 1 | 2012 | 55 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 9 | 2019 | 10827 | 0.100 |
Why?
|
| Endopeptidase Clp | 1 | 2012 | 42 | 0.100 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 2013 | 192 | 0.100 |
Why?
|
| Recombinant Proteins | 2 | 2020 | 6538 | 0.100 |
Why?
|
| Electron Transport | 1 | 2013 | 206 | 0.100 |
Why?
|
| Retrospective Studies | 22 | 2019 | 80372 | 0.100 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1994 | 783 | 0.100 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2018 | 819 | 0.100 |
Why?
|
| Bacterial Toxins | 2 | 2015 | 931 | 0.100 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2020 | 1928 | 0.100 |
Why?
|
| Recovery of Function | 1 | 2002 | 2985 | 0.100 |
Why?
|
| Multipotent Stem Cells | 1 | 2013 | 200 | 0.100 |
Why?
|
| Space Flight | 1 | 1995 | 214 | 0.100 |
Why?
|
| Organoids | 1 | 2018 | 729 | 0.100 |
Why?
|
| Genes, Viral | 1 | 2013 | 650 | 0.100 |
Why?
|
| Erythropoiesis | 3 | 2024 | 682 | 0.100 |
Why?
|
| DNA Restriction Enzymes | 1 | 2012 | 553 | 0.100 |
Why?
|
| Adhesins, Bacterial | 1 | 2012 | 118 | 0.100 |
Why?
|
| Ebolavirus | 1 | 2014 | 251 | 0.100 |
Why?
|
| Ultrasonic Therapy | 1 | 1994 | 215 | 0.100 |
Why?
|
| Odds Ratio | 6 | 2017 | 9716 | 0.100 |
Why?
|
| Pandemics | 2 | 2023 | 8624 | 0.100 |
Why?
|
| Phagocytosis | 1 | 2017 | 1535 | 0.100 |
Why?
|
| DNA Fragmentation | 1 | 2012 | 237 | 0.100 |
Why?
|
| Genetic Code | 1 | 2012 | 138 | 0.100 |
Why?
|
| Disorders of Sex Development | 1 | 2013 | 128 | 0.100 |
Why?
|
| beta-Lactams | 1 | 2013 | 157 | 0.100 |
Why?
|
| Longitudinal Studies | 4 | 2024 | 14495 | 0.100 |
Why?
|
| Lymphocyte Activation | 4 | 2018 | 5496 | 0.100 |
Why?
|
| Natural Language Processing | 1 | 2020 | 1135 | 0.100 |
Why?
|
| Motor Neurons | 2 | 1999 | 865 | 0.100 |
Why?
|
| Carbonyl Cyanide m-Chlorophenyl Hydrazone | 1 | 2011 | 22 | 0.100 |
Why?
|
| Proton-Motive Force | 1 | 2011 | 8 | 0.100 |
Why?
|
| Gene Amplification | 1 | 2016 | 1085 | 0.100 |
Why?
|
| Databases, Factual | 4 | 2019 | 8035 | 0.100 |
Why?
|
| Testis | 2 | 2014 | 794 | 0.100 |
Why?
|
| Upper Extremity | 1 | 2016 | 661 | 0.100 |
Why?
|
| Administration, Inhalation | 4 | 2008 | 1156 | 0.100 |
Why?
|
| Automation | 1 | 2014 | 580 | 0.100 |
Why?
|
| Soil Pollutants | 1 | 2012 | 70 | 0.100 |
Why?
|
| Antigens, Viral | 4 | 1978 | 980 | 0.100 |
Why?
|
| Heart Valves | 1 | 1993 | 285 | 0.100 |
Why?
|
| Erythropoietin | 1 | 2016 | 720 | 0.100 |
Why?
|
| DNA, Helminth | 1 | 2011 | 35 | 0.100 |
Why?
|
| Genetic Association Studies | 3 | 2018 | 2717 | 0.100 |
Why?
|
| Chorioamnionitis | 1 | 2012 | 156 | 0.100 |
Why?
|
| Biological Clocks | 1 | 1994 | 316 | 0.100 |
Why?
|
| Animal Structures | 1 | 2011 | 24 | 0.100 |
Why?
|
| Ribonucleoproteins | 1 | 2014 | 372 | 0.100 |
Why?
|
| Central Nervous System | 1 | 1998 | 1334 | 0.100 |
Why?
|
| Melanoma | 3 | 2021 | 5697 | 0.090 |
Why?
|
| RNA, Small Interfering | 3 | 2016 | 3442 | 0.090 |
Why?
|
| Reproducibility of Results | 8 | 2014 | 20080 | 0.090 |
Why?
|
| Anabolic Agents | 1 | 2013 | 253 | 0.090 |
Why?
|
| Cell Cycle Proteins | 2 | 2022 | 3446 | 0.090 |
Why?
|
| Friend murine leukemia virus | 5 | 1983 | 37 | 0.090 |
Why?
|
| Biological Products | 1 | 2020 | 916 | 0.090 |
Why?
|
| Culicidae | 1 | 2011 | 108 | 0.090 |
Why?
|
| Eye | 1 | 2015 | 710 | 0.090 |
Why?
|
| Disulfides | 1 | 2013 | 466 | 0.090 |
Why?
|
| Chromosomes, Bacterial | 1 | 2012 | 280 | 0.090 |
Why?
|
| Safety Management | 2 | 2007 | 760 | 0.090 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2021 | 1454 | 0.090 |
Why?
|
| Birth Certificates | 1 | 2011 | 70 | 0.090 |
Why?
|
| Phosphatidylserines | 1 | 2012 | 188 | 0.090 |
Why?
|
| North America | 1 | 2014 | 1284 | 0.090 |
Why?
|
| Guanine | 1 | 2012 | 278 | 0.090 |
Why?
|
| Wounds and Injuries | 1 | 2003 | 2477 | 0.090 |
Why?
|
| Electromyography | 4 | 2003 | 1388 | 0.090 |
Why?
|
| Insect Vectors | 1 | 2011 | 134 | 0.090 |
Why?
|
| Genes, Recessive | 1 | 2013 | 626 | 0.090 |
Why?
|
| Radiography, Interventional | 1 | 2018 | 1114 | 0.090 |
Why?
|
| Treatment Outcome | 17 | 2024 | 65017 | 0.090 |
Why?
|
| Homeostasis | 1 | 2022 | 3306 | 0.090 |
Why?
|
| Bioreactors | 1 | 2012 | 244 | 0.090 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2013 | 483 | 0.090 |
Why?
|
| Peptide Elongation Factors | 1 | 2010 | 62 | 0.090 |
Why?
|
| Acrylamide | 2 | 2007 | 59 | 0.090 |
Why?
|
| Trimethadione | 2 | 2008 | 2 | 0.090 |
Why?
|
| Rifamycins | 1 | 2010 | 26 | 0.090 |
Why?
|
| Analgesia | 1 | 1995 | 459 | 0.090 |
Why?
|
| Erythrocyte Indices | 1 | 1991 | 145 | 0.090 |
Why?
|
| Antineoplastic Agents | 2 | 2014 | 13630 | 0.090 |
Why?
|
| Nuclear Proteins | 2 | 2016 | 5791 | 0.090 |
Why?
|
| Urinary Bladder Neoplasms | 3 | 1999 | 2276 | 0.090 |
Why?
|
| DNA-Directed RNA Polymerases | 2 | 2010 | 367 | 0.090 |
Why?
|
| Serotonin | 1 | 2015 | 1040 | 0.090 |
Why?
|
| Cell Cycle | 1 | 1998 | 2934 | 0.090 |
Why?
|
| Platelet Aggregation | 2 | 2012 | 805 | 0.090 |
Why?
|
| Dystroglycans | 1 | 2010 | 62 | 0.090 |
Why?
|
| Neuropeptides | 1 | 2016 | 943 | 0.090 |
Why?
|
| Blood Cell Count | 1 | 1991 | 397 | 0.090 |
Why?
|
| Octamer Transcription Factor-3 | 3 | 2017 | 223 | 0.090 |
Why?
|
| Biofuels | 1 | 2010 | 43 | 0.090 |
Why?
|
| Chronic Disease | 1 | 2005 | 9287 | 0.090 |
Why?
|
| Nucleic Acid Synthesis Inhibitors | 1 | 2010 | 111 | 0.090 |
Why?
|
| Nerve Regeneration | 1 | 2016 | 791 | 0.090 |
Why?
|
| Inflammation | 3 | 2018 | 10756 | 0.090 |
Why?
|
| Pain | 4 | 2000 | 5066 | 0.090 |
Why?
|
| Hyperthermia, Induced | 1 | 1994 | 417 | 0.090 |
Why?
|
| Ovary | 1 | 2014 | 958 | 0.090 |
Why?
|
| Pregnancy | 9 | 2023 | 29749 | 0.090 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2016 | 3602 | 0.090 |
Why?
|
| Technology, Pharmaceutical | 1 | 2010 | 84 | 0.090 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2018 | 1810 | 0.090 |
Why?
|
| Cholesterol | 1 | 2019 | 2924 | 0.090 |
Why?
|
| Genetic Testing | 2 | 2020 | 3531 | 0.090 |
Why?
|
| Bioelectric Energy Sources | 1 | 2009 | 15 | 0.090 |
Why?
|
| Flocculation | 1 | 2009 | 3 | 0.080 |
Why?
|
| Integrin alpha Chains | 1 | 2010 | 95 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2012 | 642 | 0.080 |
Why?
|
| Macaca mulatta | 1 | 2016 | 2316 | 0.080 |
Why?
|
| Reoperation | 13 | 1997 | 4291 | 0.080 |
Why?
|
| Survival Analysis | 10 | 2009 | 10182 | 0.080 |
Why?
|
| Scotoma | 1 | 1990 | 130 | 0.080 |
Why?
|
| Cell Transplantation | 1 | 2011 | 472 | 0.080 |
Why?
|
| Infant | 11 | 2018 | 36060 | 0.080 |
Why?
|
| Fingers | 2 | 2003 | 506 | 0.080 |
Why?
|
| Host-Pathogen Interactions | 1 | 2018 | 1447 | 0.080 |
Why?
|
| HeLa Cells | 1 | 2015 | 3105 | 0.080 |
Why?
|
| Head | 1 | 2015 | 922 | 0.080 |
Why?
|
| Methylmethacrylates | 1 | 1989 | 67 | 0.080 |
Why?
|
| Neurosurgery | 1 | 1996 | 670 | 0.080 |
Why?
|
| Kidney Diseases | 1 | 2020 | 2093 | 0.080 |
Why?
|
| Light | 1 | 2015 | 1344 | 0.080 |
Why?
|
| Caspases | 1 | 2012 | 878 | 0.080 |
Why?
|
| Antiviral Agents | 1 | 2021 | 3061 | 0.080 |
Why?
|
| Hematologic Tests | 1 | 2010 | 238 | 0.080 |
Why?
|
| Interleukin-1 | 1 | 2012 | 1249 | 0.080 |
Why?
|
| Sequence Analysis, Protein | 1 | 2010 | 258 | 0.080 |
Why?
|
| Myocardial Ischemia | 2 | 2016 | 2164 | 0.080 |
Why?
|
| Manufactured Materials | 1 | 2008 | 17 | 0.080 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2012 | 556 | 0.080 |
Why?
|
| Infant, Newborn | 7 | 2018 | 26181 | 0.080 |
Why?
|
| Cross-Sectional Studies | 9 | 2017 | 25942 | 0.080 |
Why?
|
| Sodium | 1 | 2014 | 1594 | 0.080 |
Why?
|
| Fibronectins | 1 | 2012 | 722 | 0.080 |
Why?
|
| Protein Denaturation | 1 | 2008 | 242 | 0.080 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2024 | 10344 | 0.080 |
Why?
|
| Antigens, CD34 | 3 | 2019 | 653 | 0.080 |
Why?
|
| Protein Structure, Tertiary | 1 | 2015 | 3800 | 0.080 |
Why?
|
| Analgesics | 1 | 1995 | 1065 | 0.080 |
Why?
|
| Colony Count, Microbial | 2 | 2007 | 328 | 0.080 |
Why?
|
| Selenoproteins | 1 | 2010 | 214 | 0.080 |
Why?
|
| Drug Resistance | 3 | 2022 | 1617 | 0.080 |
Why?
|
| Dyneins | 1 | 2008 | 124 | 0.080 |
Why?
|
| Stroke | 3 | 2006 | 9962 | 0.080 |
Why?
|
| Pulmonary Edema | 1 | 2011 | 409 | 0.080 |
Why?
|
| 2,2'-Dipyridyl | 1 | 2007 | 11 | 0.080 |
Why?
|
| Carbon-Sulfur Lyases | 1 | 2007 | 11 | 0.080 |
Why?
|
| Neuroblastoma | 1 | 2016 | 1252 | 0.080 |
Why?
|
| Glucocorticoids | 2 | 2020 | 2145 | 0.080 |
Why?
|
| Kidney | 3 | 2020 | 7064 | 0.070 |
Why?
|
| Regenerative Medicine | 1 | 2011 | 307 | 0.070 |
Why?
|
| Simian virus 40 | 3 | 1973 | 291 | 0.070 |
Why?
|
| Actuarial Analysis | 5 | 1998 | 374 | 0.070 |
Why?
|
| HIV-1 | 1 | 2005 | 6849 | 0.070 |
Why?
|
| Tissue Donors | 1 | 2017 | 2313 | 0.070 |
Why?
|
| Ferrous Compounds | 1 | 2007 | 41 | 0.070 |
Why?
|
| Evolution, Molecular | 2 | 2014 | 1885 | 0.070 |
Why?
|
| Actins | 1 | 2015 | 2049 | 0.070 |
Why?
|
| Data Interpretation, Statistical | 2 | 2010 | 2696 | 0.070 |
Why?
|
| Homeodomain Proteins | 2 | 2014 | 2414 | 0.070 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2014 | 806 | 0.070 |
Why?
|
| Double-Blind Method | 6 | 2024 | 12427 | 0.070 |
Why?
|
| Molecular Epidemiology | 2 | 2017 | 469 | 0.070 |
Why?
|
| Keratinocytes | 1 | 2011 | 792 | 0.070 |
Why?
|
| ras Proteins | 1 | 2013 | 1052 | 0.070 |
Why?
|
| Pyridones | 1 | 2013 | 792 | 0.070 |
Why?
|
| Leukemia Virus, Murine | 2 | 1978 | 94 | 0.070 |
Why?
|
| Antibodies, Viral | 5 | 2022 | 3143 | 0.070 |
Why?
|
| Acrylamides | 1 | 1989 | 260 | 0.070 |
Why?
|
| Human Growth Hormone | 1 | 2012 | 638 | 0.070 |
Why?
|
| Growth Disorders | 1 | 2012 | 653 | 0.070 |
Why?
|
| Planning Techniques | 2 | 2000 | 82 | 0.070 |
Why?
|
| Smoking | 6 | 2010 | 9073 | 0.070 |
Why?
|
| DNA Repair | 2 | 2014 | 2039 | 0.070 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2009 | 285 | 0.070 |
Why?
|
| Intestinal Mucosa | 2 | 2015 | 3022 | 0.070 |
Why?
|
| Hip Joint | 3 | 2001 | 1006 | 0.070 |
Why?
|
| Diabetes Mellitus | 1 | 2006 | 5889 | 0.070 |
Why?
|
| Health Education | 1 | 1994 | 1049 | 0.070 |
Why?
|
| Fertility Agents, Female | 1 | 2007 | 101 | 0.070 |
Why?
|
| Drosophila melanogaster | 1 | 2016 | 1710 | 0.070 |
Why?
|
| Cell Wall | 1 | 2010 | 425 | 0.070 |
Why?
|
| Tocotrienols | 1 | 2006 | 3 | 0.070 |
Why?
|
| Exercise Test | 2 | 2014 | 2128 | 0.070 |
Why?
|
| Interneurons | 1 | 1992 | 591 | 0.070 |
Why?
|
| Intestines | 2 | 2012 | 1907 | 0.070 |
Why?
|
| Drug Therapy | 1 | 2010 | 504 | 0.070 |
Why?
|
| Ginkgo biloba | 1 | 2006 | 26 | 0.070 |
Why?
|
| Nitrogen Fixation | 1 | 1986 | 63 | 0.070 |
Why?
|
| Cell Survival | 4 | 2021 | 5797 | 0.070 |
Why?
|
| Cardiomyopathies | 2 | 2014 | 1952 | 0.070 |
Why?
|
| Cardiac Surgical Procedures | 4 | 1999 | 3620 | 0.070 |
Why?
|
| Gestational Age | 2 | 2017 | 3565 | 0.070 |
Why?
|
| Health Status | 1 | 2000 | 4081 | 0.070 |
Why?
|
| Free Radical Scavengers | 1 | 2007 | 211 | 0.070 |
Why?
|
| Blindness | 1 | 1990 | 582 | 0.070 |
Why?
|
| Ethylenediamines | 1 | 2006 | 57 | 0.070 |
Why?
|
| Iron Chelating Agents | 1 | 2007 | 138 | 0.070 |
Why?
|
| Furans | 1 | 2007 | 199 | 0.070 |
Why?
|
| Diphtheria Toxin | 1 | 2007 | 252 | 0.070 |
Why?
|
| Isopropyl Thiogalactoside | 1 | 2006 | 11 | 0.070 |
Why?
|
| Anemia | 1 | 2016 | 1511 | 0.070 |
Why?
|
| Body Weight | 6 | 2017 | 4611 | 0.070 |
Why?
|
| Surgical Wound Infection | 1 | 1996 | 1527 | 0.070 |
Why?
|
| Protein Precursors | 1 | 2010 | 1134 | 0.070 |
Why?
|
| Visual Perception | 1 | 1995 | 1374 | 0.070 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2007 | 282 | 0.070 |
Why?
|
| Cricetinae | 3 | 2007 | 2427 | 0.070 |
Why?
|
| Cell Biology | 1 | 2007 | 90 | 0.070 |
Why?
|
| Models, Animal | 2 | 2010 | 2117 | 0.070 |
Why?
|
| Salicylates | 1 | 2006 | 127 | 0.070 |
Why?
|
| Collagen | 2 | 2013 | 2636 | 0.070 |
Why?
|
| Insulin Resistance | 1 | 2020 | 3959 | 0.070 |
Why?
|
| Nursing Staff | 1 | 2007 | 113 | 0.070 |
Why?
|
| Job Description | 1 | 2006 | 59 | 0.070 |
Why?
|
| Organizational Policy | 2 | 2007 | 429 | 0.070 |
Why?
|
| Case-Control Studies | 6 | 2018 | 22053 | 0.060 |
Why?
|
| Occupations | 1 | 2008 | 515 | 0.060 |
Why?
|
| Stilbenes | 1 | 2006 | 155 | 0.060 |
Why?
|
| Chemotaxis | 1 | 2008 | 598 | 0.060 |
Why?
|
| Cricetulus | 1 | 2007 | 815 | 0.060 |
Why?
|
| Blood Transfusion | 1 | 1992 | 1328 | 0.060 |
Why?
|
| Prostate | 1 | 2013 | 1793 | 0.060 |
Why?
|
| Cell Line, Tumor | 5 | 2021 | 16939 | 0.060 |
Why?
|
| Drug Administration Schedule | 5 | 1996 | 4899 | 0.060 |
Why?
|
| Recurrence | 4 | 2015 | 8482 | 0.060 |
Why?
|
| Anorexia | 1 | 2006 | 154 | 0.060 |
Why?
|
| Treatment Failure | 1 | 2011 | 2648 | 0.060 |
Why?
|
| Thioredoxin-Disulfide Reductase | 1 | 2005 | 44 | 0.060 |
Why?
|
| Chemotherapy, Adjuvant | 2 | 2009 | 3529 | 0.060 |
Why?
|
| DNA Copy Number Variations | 1 | 2014 | 2013 | 0.060 |
Why?
|
| Valproic Acid | 1 | 2008 | 441 | 0.060 |
Why?
|
| Phenols | 1 | 2009 | 514 | 0.060 |
Why?
|
| Analysis of Variance | 4 | 2004 | 6238 | 0.060 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2006 | 352 | 0.060 |
Why?
|
| Prosthesis Design | 4 | 2001 | 2135 | 0.060 |
Why?
|
| Ubiquinone | 1 | 2006 | 183 | 0.060 |
Why?
|
| Ischemic Attack, Transient | 1 | 1990 | 901 | 0.060 |
Why?
|
| Fetal Blood | 1 | 2011 | 1343 | 0.060 |
Why?
|
| Kidney Transplantation | 1 | 2020 | 4215 | 0.060 |
Why?
|
| Integrases | 1 | 2007 | 516 | 0.060 |
Why?
|
| Infant Mortality | 1 | 2010 | 757 | 0.060 |
Why?
|
| Protein Folding | 1 | 2008 | 867 | 0.060 |
Why?
|
| Sensitivity and Specificity | 5 | 2021 | 14660 | 0.060 |
Why?
|
| CHO Cells | 1 | 2007 | 1389 | 0.060 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2012 | 1728 | 0.060 |
Why?
|
| Cell Communication | 2 | 2022 | 1653 | 0.060 |
Why?
|
| Nerve Tissue Proteins | 1 | 2017 | 4407 | 0.060 |
Why?
|
| Research Design | 3 | 2010 | 6180 | 0.060 |
Why?
|
| Spirometry | 2 | 2017 | 924 | 0.060 |
Why?
|
| Transforming Growth Factor beta | 1 | 2012 | 1959 | 0.060 |
Why?
|
| Vital Capacity | 2 | 2017 | 965 | 0.060 |
Why?
|
| Galactosides | 1 | 2024 | 54 | 0.060 |
Why?
|
| Sexual Development | 1 | 2024 | 40 | 0.060 |
Why?
|
| T-Lymphocytes | 2 | 2013 | 10181 | 0.060 |
Why?
|
| Diffusion | 2 | 2017 | 813 | 0.060 |
Why?
|
| Biophysical Phenomena | 3 | 2017 | 320 | 0.060 |
Why?
|
| Peptide Synthases | 1 | 2024 | 80 | 0.060 |
Why?
|
| Heart Ventricles | 3 | 2014 | 3811 | 0.060 |
Why?
|
| Epithelium | 1 | 2009 | 1605 | 0.060 |
Why?
|
| Mannitol | 1 | 2024 | 180 | 0.060 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2021 | 3075 | 0.060 |
Why?
|
| Behavioral Symptoms | 1 | 2006 | 185 | 0.060 |
Why?
|
| Cyclic AMP | 1 | 2008 | 1456 | 0.060 |
Why?
|
| Nitriles | 1 | 1989 | 956 | 0.060 |
Why?
|
| Switzerland | 1 | 2024 | 323 | 0.060 |
Why?
|
| Causality | 2 | 2007 | 1242 | 0.060 |
Why?
|
| Publication Bias | 1 | 2004 | 162 | 0.060 |
Why?
|
| Genetics | 1 | 2004 | 114 | 0.060 |
Why?
|
| Binding Sites | 2 | 2015 | 6048 | 0.060 |
Why?
|
| Hazardous Substances | 1 | 2004 | 152 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 3 | 2010 | 6068 | 0.060 |
Why?
|
| MAP Kinase Signaling System | 1 | 2011 | 1484 | 0.060 |
Why?
|
| Autophagy | 1 | 2011 | 1337 | 0.060 |
Why?
|
| Thioredoxins | 1 | 2005 | 201 | 0.060 |
Why?
|
| Animals, Wild | 1 | 2023 | 77 | 0.060 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2006 | 238 | 0.060 |
Why?
|
| NAD | 1 | 2007 | 609 | 0.050 |
Why?
|
| Fenbendazole | 1 | 2022 | 1 | 0.050 |
Why?
|
| Pyrantel Pamoate | 1 | 2022 | 1 | 0.050 |
Why?
|
| B-Lymphocytes | 2 | 2014 | 4742 | 0.050 |
Why?
|
| Ancylostomatoidea | 1 | 2022 | 5 | 0.050 |
Why?
|
| Muscle Weakness | 2 | 2018 | 413 | 0.050 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2010 | 1827 | 0.050 |
Why?
|
| Ancylostoma | 1 | 2022 | 10 | 0.050 |
Why?
|
| Parasite Egg Count | 1 | 2022 | 29 | 0.050 |
Why?
|
| Oceans and Seas | 1 | 2023 | 47 | 0.050 |
Why?
|
| Genetic Heterogeneity | 1 | 2006 | 724 | 0.050 |
Why?
|
| Fetal Development | 1 | 2009 | 766 | 0.050 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 1992 | 1311 | 0.050 |
Why?
|
| Prenatal Care | 1 | 2011 | 1129 | 0.050 |
Why?
|
| Administration, Oral | 5 | 2008 | 4035 | 0.050 |
Why?
|
| Educational Status | 1 | 2011 | 2515 | 0.050 |
Why?
|
| Heart Valve Diseases | 4 | 1999 | 1047 | 0.050 |
Why?
|
| Clinical Trials, Phase I as Topic | 1 | 2024 | 326 | 0.050 |
Why?
|
| Immunosorbents | 1 | 2022 | 21 | 0.050 |
Why?
|
| London | 1 | 2023 | 234 | 0.050 |
Why?
|
| 5' Untranslated Regions | 1 | 2004 | 256 | 0.050 |
Why?
|
| Trachea | 1 | 2009 | 1082 | 0.050 |
Why?
|
| Coral Reefs | 1 | 2023 | 34 | 0.050 |
Why?
|
| Nucleotides | 2 | 2016 | 450 | 0.050 |
Why?
|
| Pain Measurement | 3 | 1999 | 3528 | 0.050 |
Why?
|
| Testosterone | 1 | 2013 | 2470 | 0.050 |
Why?
|
| Aortic Valve Stenosis | 3 | 1998 | 2065 | 0.050 |
Why?
|
| Plant Extracts | 1 | 2006 | 496 | 0.050 |
Why?
|
| Quality Improvement | 1 | 2018 | 3836 | 0.050 |
Why?
|
| Systems Theory | 1 | 2002 | 57 | 0.050 |
Why?
|
| Georgia | 1 | 2022 | 190 | 0.050 |
Why?
|
| Binomial Distribution | 1 | 2002 | 23 | 0.050 |
Why?
|
| Half-Life | 3 | 2014 | 652 | 0.050 |
Why?
|
| Splints | 1 | 2023 | 107 | 0.050 |
Why?
|
| Organometallic Compounds | 1 | 2006 | 662 | 0.050 |
Why?
|
| Mesonephros | 1 | 2022 | 42 | 0.050 |
Why?
|
| Mitomycin | 1 | 2003 | 262 | 0.050 |
Why?
|
| Ankle Joint | 2 | 1998 | 435 | 0.050 |
Why?
|
| RNA, Fungal | 1 | 2003 | 160 | 0.050 |
Why?
|
| Lentivirus | 1 | 2005 | 506 | 0.050 |
Why?
|
| Defoliants, Chemical | 1 | 2001 | 9 | 0.050 |
Why?
|
| Arthroscopy | 1 | 1989 | 960 | 0.050 |
Why?
|
| Sex Characteristics | 1 | 2013 | 2629 | 0.050 |
Why?
|
| Immunohistochemistry | 2 | 2013 | 11071 | 0.050 |
Why?
|
| Rats, Inbred F344 | 4 | 1992 | 825 | 0.050 |
Why?
|
| Burkholderia cepacia | 1 | 2002 | 22 | 0.050 |
Why?
|
| Controlled Clinical Trials as Topic | 1 | 2003 | 186 | 0.050 |
Why?
|
| Models, Molecular | 1 | 2012 | 5434 | 0.050 |
Why?
|
| DNA Probes | 1 | 2023 | 551 | 0.050 |
Why?
|
| Lac Operon | 1 | 2002 | 237 | 0.050 |
Why?
|
| Hospitalization | 2 | 2019 | 10790 | 0.050 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2024 | 629 | 0.050 |
Why?
|
| bcl-Associated Death Protein | 1 | 2022 | 102 | 0.050 |
Why?
|
| Vitamin E | 1 | 2006 | 872 | 0.050 |
Why?
|
| Immune Complex Diseases | 1 | 1981 | 52 | 0.050 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2021 | 15789 | 0.050 |
Why?
|
| Stress, Mechanical | 3 | 1996 | 1666 | 0.050 |
Why?
|
| Software | 3 | 2012 | 4419 | 0.050 |
Why?
|
| Burkholderia Infections | 1 | 2002 | 41 | 0.050 |
Why?
|
| Macrolides | 1 | 2022 | 206 | 0.050 |
Why?
|
| Mastoid | 1 | 2002 | 98 | 0.050 |
Why?
|
| Reference Values | 5 | 2008 | 4925 | 0.050 |
Why?
|
| Genetic Vectors | 2 | 2015 | 3380 | 0.050 |
Why?
|
| Protein Isoforms | 2 | 2018 | 1697 | 0.050 |
Why?
|
| Cross Reactions | 1 | 2023 | 818 | 0.050 |
Why?
|
| Antibodies, Neoplasm | 2 | 1980 | 280 | 0.050 |
Why?
|
| Catalysis | 1 | 2023 | 775 | 0.050 |
Why?
|
| Skin Neoplasms | 1 | 2021 | 5799 | 0.050 |
Why?
|
| Heart Septal Defects, Atrial | 2 | 1996 | 461 | 0.050 |
Why?
|
| Infertility, Female | 1 | 2007 | 759 | 0.050 |
Why?
|
| Protein Interaction Mapping | 1 | 2005 | 617 | 0.050 |
Why?
|
| Workplace | 2 | 2006 | 857 | 0.050 |
Why?
|
| Bacteriophage lambda | 1 | 2001 | 142 | 0.050 |
Why?
|
| Toxicity Tests | 1 | 2001 | 111 | 0.050 |
Why?
|
| Hemodynamics | 6 | 1995 | 4174 | 0.050 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2015 | 2421 | 0.050 |
Why?
|
| Inservice Training | 2 | 2018 | 375 | 0.050 |
Why?
|
| RNA Splice Sites | 1 | 2022 | 211 | 0.050 |
Why?
|
| 3' Untranslated Regions | 2 | 2016 | 514 | 0.050 |
Why?
|
| Calcium | 1 | 2014 | 5725 | 0.050 |
Why?
|
| Hematologic Neoplasms | 2 | 2004 | 1895 | 0.050 |
Why?
|
| Musculoskeletal Diseases | 1 | 2006 | 595 | 0.050 |
Why?
|
| Receptors, Androgen | 1 | 2007 | 1077 | 0.040 |
Why?
|
| Cell Transformation, Neoplastic | 5 | 1981 | 2828 | 0.040 |
Why?
|
| Logistic Models | 5 | 2011 | 13314 | 0.040 |
Why?
|
| Freeze Drying | 1 | 2020 | 101 | 0.040 |
Why?
|
| Venoms | 1 | 2020 | 96 | 0.040 |
Why?
|
| Doxycycline | 2 | 2012 | 341 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2021 | 3584 | 0.040 |
Why?
|
| Sutures | 2 | 1994 | 293 | 0.040 |
Why?
|
| Netherlands | 4 | 2007 | 2213 | 0.040 |
Why?
|
| Air Pollutants | 1 | 1994 | 2844 | 0.040 |
Why?
|
| Plankton | 1 | 1999 | 21 | 0.040 |
Why?
|
| Prosthesis-Related Infections | 3 | 1995 | 487 | 0.040 |
Why?
|
| Pediatrics | 1 | 1995 | 3586 | 0.040 |
Why?
|
| Yeasts | 1 | 2001 | 279 | 0.040 |
Why?
|
| Snails | 1 | 2019 | 21 | 0.040 |
Why?
|
| Erythroblasts | 1 | 2020 | 143 | 0.040 |
Why?
|
| Rubber | 1 | 1999 | 47 | 0.040 |
Why?
|
| Contract Services | 1 | 2000 | 89 | 0.040 |
Why?
|
| England | 2 | 2019 | 526 | 0.040 |
Why?
|
| Cooperative Behavior | 1 | 2007 | 1500 | 0.040 |
Why?
|
| Learning | 1 | 2009 | 1739 | 0.040 |
Why?
|
| Pressure | 3 | 1993 | 1156 | 0.040 |
Why?
|
| Somatosensory Cortex | 1 | 2003 | 511 | 0.040 |
Why?
|
| Endocarditis, Bacterial | 2 | 1994 | 445 | 0.040 |
Why?
|
| Glomerulonephritis | 1 | 1981 | 337 | 0.040 |
Why?
|
| Electrodes | 1 | 2002 | 614 | 0.040 |
Why?
|
| Adenosine Monophosphate | 1 | 2021 | 283 | 0.040 |
Why?
|
| Antigens, CD | 1 | 2010 | 4000 | 0.040 |
Why?
|
| Health Status Disparities | 1 | 2011 | 1830 | 0.040 |
Why?
|
| Microarray Analysis | 2 | 2012 | 747 | 0.040 |
Why?
|
| Health Status Indicators | 1 | 2004 | 968 | 0.040 |
Why?
|
| Introns | 1 | 2022 | 978 | 0.040 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2014 | 5253 | 0.040 |
Why?
|
| Mice, Transgenic | 3 | 2017 | 9530 | 0.040 |
Why?
|
| Heart Transplantation | 5 | 1992 | 3224 | 0.040 |
Why?
|
| Plasma | 1 | 2022 | 584 | 0.040 |
Why?
|
| Aptamers, Nucleotide | 1 | 2020 | 172 | 0.040 |
Why?
|
| Endometriosis | 1 | 2007 | 874 | 0.040 |
Why?
|
| Peripheral Nerves | 1 | 2002 | 475 | 0.040 |
Why?
|
| Dust | 1 | 2001 | 483 | 0.040 |
Why?
|
| Acinetobacter | 1 | 2018 | 39 | 0.040 |
Why?
|
| Employment | 1 | 2005 | 1112 | 0.040 |
Why?
|
| New South Wales | 1 | 1998 | 70 | 0.040 |
Why?
|
| Games, Experimental | 1 | 1998 | 32 | 0.040 |
Why?
|
| Pedigree | 2 | 2017 | 4578 | 0.040 |
Why?
|
| Health Facilities | 1 | 2003 | 578 | 0.040 |
Why?
|
| Sentinel Surveillance | 1 | 2000 | 293 | 0.040 |
Why?
|
| Arteriosclerosis | 3 | 1997 | 1064 | 0.040 |
Why?
|
| False Positive Reactions | 1 | 2021 | 956 | 0.040 |
Why?
|
| RecQ Helicases | 1 | 2018 | 53 | 0.040 |
Why?
|
| Dogs | 2 | 2022 | 3841 | 0.040 |
Why?
|
| Sequence Analysis | 1 | 2018 | 240 | 0.040 |
Why?
|
| Air Pollution | 2 | 2011 | 2317 | 0.040 |
Why?
|
| Clinical Trials as Topic | 2 | 2011 | 8056 | 0.040 |
Why?
|
| Policy Making | 1 | 2001 | 538 | 0.040 |
Why?
|
| Axillary Vein | 1 | 1997 | 14 | 0.040 |
Why?
|
| Northern Territory | 1 | 1997 | 5 | 0.040 |
Why?
|
| Saliva | 1 | 2022 | 820 | 0.040 |
Why?
|
| Proteomics | 3 | 2018 | 3817 | 0.040 |
Why?
|
| Commerce | 1 | 2023 | 605 | 0.040 |
Why?
|
| Solubility | 1 | 2019 | 1088 | 0.040 |
Why?
|
| Fluorescence | 1 | 2020 | 751 | 0.040 |
Why?
|
| Spleen | 1 | 2024 | 2298 | 0.040 |
Why?
|
| Axillary Artery | 1 | 1997 | 48 | 0.040 |
Why?
|
| Antibiotics, Antitubercular | 1 | 2018 | 100 | 0.040 |
Why?
|
| Virus Replication | 1 | 2005 | 2432 | 0.040 |
Why?
|
| Base Pairing | 1 | 2017 | 140 | 0.040 |
Why?
|
| Pulmonary Atelectasis | 1 | 1998 | 143 | 0.040 |
Why?
|
| Spinal Nerve Roots | 1 | 2017 | 121 | 0.040 |
Why?
|
| Muscle Spindles | 1 | 1996 | 15 | 0.040 |
Why?
|
| Epilepsy | 1 | 2012 | 3267 | 0.040 |
Why?
|
| Acute Disease | 4 | 1996 | 7269 | 0.040 |
Why?
|
| Glioblastoma | 1 | 2012 | 3484 | 0.040 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2022 | 727 | 0.040 |
Why?
|
| Nausea | 1 | 2000 | 678 | 0.040 |
Why?
|
| Boston | 6 | 1996 | 9280 | 0.040 |
Why?
|
| Femoral Vein | 1 | 1997 | 153 | 0.040 |
Why?
|
| Peptide Chain Initiation, Translational | 1 | 2017 | 100 | 0.030 |
Why?
|
| Infant Formula | 1 | 2018 | 193 | 0.030 |
Why?
|
| Age of Onset | 2 | 2015 | 3301 | 0.030 |
Why?
|
| Stomach Neoplasms | 2 | 2001 | 1423 | 0.030 |
Why?
|
| Embolism, Cholesterol | 1 | 1996 | 33 | 0.030 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 1 | 2018 | 187 | 0.030 |
Why?
|
| Referral and Consultation | 2 | 2017 | 3598 | 0.030 |
Why?
|
| Suicide, Assisted | 1 | 1997 | 69 | 0.030 |
Why?
|
| Consanguinity | 1 | 2018 | 456 | 0.030 |
Why?
|
| Genes, vpr | 1 | 2016 | 19 | 0.030 |
Why?
|
| Administration, Cutaneous | 1 | 1999 | 713 | 0.030 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 2020 | 457 | 0.030 |
Why?
|
| Electrophysiology | 1 | 1999 | 1265 | 0.030 |
Why?
|
| Therapeutic Equivalency | 1 | 1996 | 136 | 0.030 |
Why?
|
| Fertility | 1 | 2001 | 773 | 0.030 |
Why?
|
| Cardiopulmonary Bypass | 3 | 1997 | 1096 | 0.030 |
Why?
|
| Jurkat Cells | 1 | 2018 | 736 | 0.030 |
Why?
|
| Climate Change | 1 | 2023 | 488 | 0.030 |
Why?
|
| Serum Albumin | 1 | 1999 | 674 | 0.030 |
Why?
|
| Mice, Inbred DBA | 3 | 1983 | 622 | 0.030 |
Why?
|
| Endocardial Cushion Defects | 1 | 1996 | 43 | 0.030 |
Why?
|
| Suspensions | 1 | 1996 | 66 | 0.030 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2006 | 1079 | 0.030 |
Why?
|
| Abortion, Spontaneous | 1 | 2001 | 530 | 0.030 |
Why?
|
| Methods | 2 | 1994 | 1074 | 0.030 |
Why?
|
| Data Collection | 2 | 1997 | 3315 | 0.030 |
Why?
|
| Cardioplegic Solutions | 1 | 1996 | 122 | 0.030 |
Why?
|
| Maternal Age | 1 | 2019 | 807 | 0.030 |
Why?
|
| Subarachnoid Space | 1 | 1996 | 81 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2007 | 4902 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2002 | 2852 | 0.030 |
Why?
|
| Cough | 1 | 2000 | 595 | 0.030 |
Why?
|
| Biopsy | 2 | 2018 | 6771 | 0.030 |
Why?
|
| Ganglia | 1 | 2016 | 87 | 0.030 |
Why?
|
| Embryonal Carcinoma Stem Cells | 1 | 2015 | 20 | 0.030 |
Why?
|
| Sleep Stages | 1 | 2000 | 691 | 0.030 |
Why?
|
| Therapy, Computer-Assisted | 1 | 1998 | 267 | 0.030 |
Why?
|
| Rifampin | 1 | 2018 | 340 | 0.030 |
Why?
|
| Chromatin Assembly Factor-1 | 1 | 2015 | 21 | 0.030 |
Why?
|
| Metal Nanoparticles | 1 | 2020 | 399 | 0.030 |
Why?
|
| Hemostasis, Surgical | 1 | 1996 | 129 | 0.030 |
Why?
|
| Ileus | 1 | 2015 | 57 | 0.030 |
Why?
|
| Feasibility Studies | 2 | 1999 | 5201 | 0.030 |
Why?
|
| Geriatric Assessment | 1 | 2003 | 1405 | 0.030 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2017 | 286 | 0.030 |
Why?
|
| Metals | 1 | 2020 | 736 | 0.030 |
Why?
|
| Genetic Variation | 2 | 2018 | 6551 | 0.030 |
Why?
|
| Prostheses and Implants | 2 | 1994 | 1273 | 0.030 |
Why?
|
| Mice, Nude | 3 | 2012 | 3607 | 0.030 |
Why?
|
| Drug Combinations | 1 | 2021 | 2025 | 0.030 |
Why?
|
| Australia | 1 | 2019 | 1289 | 0.030 |
Why?
|
| Small Ubiquitin-Related Modifier Proteins | 1 | 2015 | 68 | 0.030 |
Why?
|
| Equipment Design | 1 | 2003 | 3520 | 0.030 |
Why?
|
| Killer Cells, Natural | 2 | 2021 | 2203 | 0.030 |
Why?
|
| Pilot Projects | 2 | 2014 | 8555 | 0.030 |
Why?
|
| Prospective Studies | 9 | 1999 | 54303 | 0.030 |
Why?
|
| Neoplasm Transplantation | 2 | 2018 | 2014 | 0.030 |
Why?
|
| Caco-2 Cells | 1 | 2015 | 368 | 0.030 |
Why?
|
| Surgical Staplers | 2 | 1992 | 34 | 0.030 |
Why?
|
| Regulatory Sequences, Ribonucleic Acid | 1 | 2014 | 29 | 0.030 |
Why?
|
| Intraoperative Care | 2 | 1996 | 768 | 0.030 |
Why?
|
| Myopathies, Nemaline | 1 | 2015 | 73 | 0.030 |
Why?
|
| Thromboembolism | 4 | 1998 | 1017 | 0.030 |
Why?
|
| Infusions, Parenteral | 1 | 1995 | 399 | 0.030 |
Why?
|
| Immunity | 2 | 1978 | 998 | 0.030 |
Why?
|
| Glutathione | 1 | 2017 | 582 | 0.030 |
Why?
|
| Weight Loss | 1 | 2006 | 2686 | 0.030 |
Why?
|
| Sex Factors | 6 | 1992 | 10547 | 0.030 |
Why?
|
| Stem Cell Niche | 1 | 2018 | 346 | 0.030 |
Why?
|
| Open Reading Frames | 1 | 2018 | 814 | 0.030 |
Why?
|
| Conserved Sequence | 1 | 2018 | 1167 | 0.030 |
Why?
|
| Heart Arrest, Induced | 1 | 1996 | 357 | 0.030 |
Why?
|
| Volatilization | 1 | 1994 | 79 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2018 | 20509 | 0.030 |
Why?
|
| Astrocytoma | 1 | 1999 | 775 | 0.030 |
Why?
|
| Ribotyping | 1 | 2014 | 35 | 0.030 |
Why?
|
| Acetamides | 1 | 1996 | 256 | 0.030 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2017 | 503 | 0.030 |
Why?
|
| Calcinosis | 3 | 1994 | 1476 | 0.030 |
Why?
|
| Genes, Neoplasm | 1 | 2016 | 370 | 0.030 |
Why?
|
| Cybernetics | 1 | 1994 | 7 | 0.030 |
Why?
|
| Sarcoglycans | 1 | 2014 | 57 | 0.030 |
Why?
|
| Polymers | 1 | 2001 | 1621 | 0.030 |
Why?
|
| Organizational Culture | 1 | 2018 | 506 | 0.030 |
Why?
|
| Marfan Syndrome | 1 | 1996 | 236 | 0.030 |
Why?
|
| Mice, Inbred mdx | 1 | 2014 | 88 | 0.030 |
Why?
|
| Chordae Tendineae | 1 | 1994 | 39 | 0.030 |
Why?
|
| Eflornithine | 1 | 2013 | 31 | 0.030 |
Why?
|
| Blood Flow Velocity | 2 | 2001 | 1377 | 0.030 |
Why?
|
| Hypothermia, Induced | 2 | 1996 | 758 | 0.030 |
Why?
|
| Plasmodium falciparum | 1 | 2024 | 1742 | 0.030 |
Why?
|
| Tensile Strength | 1 | 1995 | 330 | 0.030 |
Why?
|
| Tetracyclines | 1 | 2014 | 65 | 0.030 |
Why?
|
| Ornithine Decarboxylase | 1 | 2013 | 64 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2019 | 3084 | 0.030 |
Why?
|
| Neurologic Examination | 1 | 2017 | 916 | 0.030 |
Why?
|
| Blood Coagulation | 1 | 1980 | 1157 | 0.030 |
Why?
|
| Absorptiometry, Photon | 1 | 2020 | 1736 | 0.030 |
Why?
|
| Body Burden | 1 | 2014 | 158 | 0.030 |
Why?
|
| Blotting, Southern | 1 | 1994 | 777 | 0.030 |
Why?
|
| Restriction Mapping | 1 | 1994 | 852 | 0.030 |
Why?
|
| Ecology | 1 | 2014 | 103 | 0.030 |
Why?
|
| Aorta | 2 | 1990 | 2039 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2018 | 1837 | 0.030 |
Why?
|
| Narcotics | 1 | 1996 | 336 | 0.030 |
Why?
|
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2014 | 114 | 0.030 |
Why?
|
| Phospholipases | 1 | 1973 | 76 | 0.030 |
Why?
|
| Catheterization | 2 | 1996 | 1432 | 0.030 |
Why?
|
| Methylation | 1 | 2016 | 1082 | 0.030 |
Why?
|
| Cerebrovascular Circulation | 2 | 2001 | 2733 | 0.030 |
Why?
|
| Myocardial Infarction | 4 | 1996 | 11891 | 0.030 |
Why?
|
| Epitopes | 3 | 1977 | 2503 | 0.030 |
Why?
|
| Reproduction, Asexual | 1 | 2013 | 14 | 0.030 |
Why?
|
| Culture | 1 | 1997 | 622 | 0.030 |
Why?
|
| Workflow | 1 | 2018 | 852 | 0.030 |
Why?
|
| Femoral Artery | 1 | 1997 | 835 | 0.030 |
Why?
|
| Sodium Channel Blockers | 1 | 2014 | 172 | 0.030 |
Why?
|
| Birth Weight | 1 | 2001 | 2097 | 0.030 |
Why?
|
| Disease Progression | 3 | 2015 | 13502 | 0.030 |
Why?
|
| Injections | 1 | 1996 | 830 | 0.030 |
Why?
|
| Sheep, Domestic | 1 | 2012 | 50 | 0.030 |
Why?
|
| Polytetrafluoroethylene | 1 | 1994 | 245 | 0.030 |
Why?
|
| Digoxin | 1 | 2014 | 247 | 0.030 |
Why?
|
| Follistatin | 1 | 2013 | 137 | 0.030 |
Why?
|
| Reaction Time | 1 | 1999 | 2075 | 0.030 |
Why?
|
| Health Personnel | 1 | 2006 | 3310 | 0.030 |
Why?
|
| Cardiac Output | 2 | 1994 | 838 | 0.030 |
Why?
|
| Musculoskeletal Physiological Phenomena | 1 | 1993 | 30 | 0.030 |
Why?
|
| Fatigue | 1 | 2000 | 1544 | 0.030 |
Why?
|
| Point Mutation | 1 | 2018 | 1594 | 0.030 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2001 | 911 | 0.030 |
Why?
|
| Genitalia, Male | 1 | 2013 | 87 | 0.030 |
Why?
|
| Anastomosis, Surgical | 1 | 1996 | 983 | 0.030 |
Why?
|
| Yolk Sac | 1 | 2012 | 79 | 0.030 |
Why?
|
| Analgesia, Epidural | 1 | 1996 | 330 | 0.030 |
Why?
|
| Acetanilides | 1 | 2014 | 169 | 0.030 |
Why?
|
| Mice, Inbred Strains | 4 | 1988 | 1763 | 0.030 |
Why?
|
| Deoxyguanine Nucleotides | 1 | 2012 | 21 | 0.030 |
Why?
|
| Interleukin-8 | 1 | 2015 | 698 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2017 | 1832 | 0.030 |
Why?
|
| Motor Activity | 1 | 2002 | 2687 | 0.030 |
Why?
|
| DNA Polymerase I | 1 | 2012 | 43 | 0.030 |
Why?
|
| Fungi | 1 | 1995 | 339 | 0.030 |
Why?
|
| Cystic Fibrosis | 1 | 2002 | 1274 | 0.030 |
Why?
|
| DNA Polymerase beta | 1 | 2012 | 20 | 0.030 |
Why?
|
| Antigens | 1 | 2018 | 1447 | 0.030 |
Why?
|
| Matrix Attachment Region Binding Proteins | 1 | 2012 | 47 | 0.030 |
Why?
|
| Erythema Chronicum Migrans | 1 | 1992 | 48 | 0.030 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2001 | 916 | 0.030 |
Why?
|
| Congresses as Topic | 1 | 2017 | 805 | 0.030 |
Why?
|
| Weight-Bearing | 1 | 1995 | 518 | 0.030 |
Why?
|
| Running | 1 | 2017 | 483 | 0.030 |
Why?
|
| Europe | 1 | 1999 | 3441 | 0.030 |
Why?
|
| Decerebrate State | 1 | 1992 | 42 | 0.030 |
Why?
|
| Lymphoid Enhancer-Binding Factor 1 | 1 | 2012 | 84 | 0.030 |
Why?
|
| Aorta, Thoracic | 2 | 1996 | 1097 | 0.030 |
Why?
|
| Turtles | 1 | 1992 | 40 | 0.030 |
Why?
|
| Scattering, Radiation | 1 | 1994 | 488 | 0.020 |
Why?
|
| Community-Acquired Infections | 1 | 1996 | 461 | 0.020 |
Why?
|
| Heart Aneurysm | 1 | 1992 | 115 | 0.020 |
Why?
|
| Respiratory Function Tests | 1 | 2017 | 1683 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2017 | 2672 | 0.020 |
Why?
|
| Terminology as Topic | 1 | 2019 | 1535 | 0.020 |
Why?
|
| Hindlimb | 1 | 2014 | 510 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2017 | 995 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 2 | 1996 | 1628 | 0.020 |
Why?
|
| Disability Evaluation | 1 | 1999 | 1826 | 0.020 |
Why?
|
| Pyrophosphatases | 1 | 2012 | 139 | 0.020 |
Why?
|
| DNA Polymerase II | 1 | 2012 | 104 | 0.020 |
Why?
|
| Heart Atria | 3 | 1994 | 1346 | 0.020 |
Why?
|
| Chromosome Deletion | 1 | 2016 | 1387 | 0.020 |
Why?
|
| GATA1 Transcription Factor | 1 | 2012 | 296 | 0.020 |
Why?
|
| RNA Splicing | 1 | 2016 | 915 | 0.020 |
Why?
|
| Heart Septum | 1 | 1992 | 303 | 0.020 |
Why?
|
| Collateral Circulation | 1 | 1972 | 292 | 0.020 |
Why?
|
| Endocarditis | 1 | 1995 | 351 | 0.020 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2014 | 477 | 0.020 |
Why?
|
| Lung | 2 | 2001 | 9994 | 0.020 |
Why?
|
| DNA Glycosylases | 1 | 2012 | 124 | 0.020 |
Why?
|
| Motion Perception | 1 | 1995 | 372 | 0.020 |
Why?
|
| Healthy Worker Effect | 1 | 2010 | 29 | 0.020 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2012 | 298 | 0.020 |
Why?
|
| Interferon Regulatory Factors | 1 | 2012 | 260 | 0.020 |
Why?
|
| Nitrofurazone | 1 | 2010 | 1 | 0.020 |
Why?
|
| Blotting, Far-Western | 1 | 2010 | 3 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2020 | 36290 | 0.020 |
Why?
|
| Zinc | 1 | 1995 | 689 | 0.020 |
Why?
|
| Ikaros Transcription Factor | 1 | 2012 | 231 | 0.020 |
Why?
|
| Genome, Human | 2 | 2016 | 4417 | 0.020 |
Why?
|
| 4-Nitroquinoline-1-oxide | 1 | 2010 | 17 | 0.020 |
Why?
|
| Biophysics | 2 | 2004 | 380 | 0.020 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2016 | 1077 | 0.020 |
Why?
|
| DNA Primers | 1 | 1995 | 2819 | 0.020 |
Why?
|
| Organ Size | 2 | 2013 | 2254 | 0.020 |
Why?
|
| Cross-Over Studies | 1 | 1996 | 2061 | 0.020 |
Why?
|
| Diagnosis-Related Groups | 1 | 1992 | 450 | 0.020 |
Why?
|
| Body Composition | 1 | 2020 | 2419 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 1995 | 2234 | 0.020 |
Why?
|
| Cats | 1 | 1992 | 976 | 0.020 |
Why?
|
| Rats, Inbred Lew | 1 | 1992 | 1154 | 0.020 |
Why?
|
| Epilepsy, Generalized | 1 | 2012 | 178 | 0.020 |
Why?
|
| Cytotoxicity Tests, Immunologic | 2 | 1983 | 321 | 0.020 |
Why?
|
| Evoked Potentials | 1 | 1996 | 1036 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2014 | 1342 | 0.020 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 1996 | 708 | 0.020 |
Why?
|
| Valine | 1 | 2011 | 409 | 0.020 |
Why?
|
| Echocardiography, Transesophageal | 1 | 1996 | 1108 | 0.020 |
Why?
|
| Breast Feeding | 1 | 2018 | 1355 | 0.020 |
Why?
|
| Health Resources | 1 | 1996 | 935 | 0.020 |
Why?
|
| Heel | 1 | 1990 | 37 | 0.020 |
Why?
|
| Maximum Allowable Concentration | 1 | 2009 | 63 | 0.020 |
Why?
|
| Probability | 2 | 2009 | 2475 | 0.020 |
Why?
|
| Interleukin-1beta | 1 | 2015 | 998 | 0.020 |
Why?
|
| Arthroscopes | 1 | 1989 | 11 | 0.020 |
Why?
|
| Genes, ras | 1 | 2012 | 655 | 0.020 |
Why?
|
| Genetic Linkage | 1 | 2015 | 2381 | 0.020 |
Why?
|
| Aortic Diseases | 2 | 1997 | 736 | 0.020 |
Why?
|
| Glycoproteins | 1 | 1977 | 2208 | 0.020 |
Why?
|
| Germany | 1 | 1992 | 873 | 0.020 |
Why?
|
| Hemarthrosis | 1 | 1989 | 39 | 0.020 |
Why?
|
| Transfection | 1 | 2017 | 5781 | 0.020 |
Why?
|
| Circadian Rhythm | 1 | 2001 | 2571 | 0.020 |
Why?
|
| Neurogenesis | 1 | 2016 | 856 | 0.020 |
Why?
|
| No-Observed-Adverse-Effect Level | 1 | 2009 | 25 | 0.020 |
Why?
|
| Methionine | 1 | 2011 | 569 | 0.020 |
Why?
|
| Nerve Block | 1 | 1996 | 688 | 0.020 |
Why?
|
| Methylmethacrylate | 1 | 1989 | 39 | 0.020 |
Why?
|
| Transcriptional Elongation Factors | 1 | 2010 | 163 | 0.020 |
Why?
|
| Health Policy | 1 | 2001 | 2677 | 0.020 |
Why?
|
| Databases, Genetic | 1 | 2016 | 1738 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2017 | 2493 | 0.020 |
Why?
|
| Thrombectomy | 1 | 1994 | 708 | 0.020 |
Why?
|
| Synaptic Transmission | 1 | 1995 | 1171 | 0.020 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2010 | 296 | 0.020 |
Why?
|
| Epilepsies, Partial | 1 | 2012 | 430 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2017 | 4107 | 0.020 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2012 | 491 | 0.020 |
Why?
|
| Thrombophlebitis | 1 | 1989 | 288 | 0.020 |
Why?
|
| Animal Experimentation | 1 | 2008 | 46 | 0.020 |
Why?
|
| Social Support | 1 | 1998 | 2145 | 0.020 |
Why?
|
| Attitude to Health | 1 | 1997 | 2029 | 0.020 |
Why?
|
| Epidemics | 1 | 2014 | 510 | 0.020 |
Why?
|
| Mesenteric Arteries | 1 | 1988 | 178 | 0.020 |
Why?
|
| Histocompatibility Testing | 1 | 1990 | 717 | 0.020 |
Why?
|
| Prevalence | 1 | 2005 | 15687 | 0.020 |
Why?
|
| Endoribonucleases | 1 | 2009 | 229 | 0.020 |
Why?
|
| Mice, Knockout | 2 | 2014 | 14372 | 0.020 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2012 | 1055 | 0.020 |
Why?
|
| Program Development | 1 | 1994 | 1297 | 0.020 |
Why?
|
| Prednisone | 1 | 2012 | 1565 | 0.020 |
Why?
|
| Danazol | 1 | 2007 | 45 | 0.020 |
Why?
|
| Hypnotics and Sedatives | 1 | 1995 | 1178 | 0.020 |
Why?
|
| Artifacts | 1 | 1996 | 1898 | 0.020 |
Why?
|
| Acne Vulgaris | 1 | 1993 | 355 | 0.020 |
Why?
|
| Feeding Behavior | 1 | 1999 | 3185 | 0.020 |
Why?
|
| Myxoma | 1 | 1988 | 114 | 0.020 |
Why?
|
| Serine Endopeptidases | 1 | 2012 | 1021 | 0.020 |
Why?
|
| Endarterectomy, Carotid | 1 | 1992 | 564 | 0.020 |
Why?
|
| Back Injuries | 1 | 2007 | 41 | 0.020 |
Why?
|
| Benzimidazoles | 1 | 2012 | 858 | 0.020 |
Why?
|
| Respiratory Tract Diseases | 2 | 1989 | 748 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2021 | 4550 | 0.020 |
Why?
|
| Bronchi | 1 | 1991 | 848 | 0.020 |
Why?
|
| Estrogen Antagonists | 1 | 2007 | 151 | 0.020 |
Why?
|
| Multicenter Studies as Topic | 1 | 1992 | 1722 | 0.020 |
Why?
|
| Protein Kinases | 1 | 2014 | 1612 | 0.020 |
Why?
|
| Wound Infection | 1 | 1989 | 244 | 0.020 |
Why?
|
| Respiration, Artificial | 1 | 1998 | 2622 | 0.020 |
Why?
|
| Nursing Assessment | 1 | 2007 | 106 | 0.020 |
Why?
|
| Animals, Genetically Modified | 1 | 2011 | 1553 | 0.020 |
Why?
|
| Ovulation | 1 | 2007 | 181 | 0.020 |
Why?
|
| Echocardiography | 4 | 1992 | 4981 | 0.020 |
Why?
|
| Coronary Circulation | 1 | 1972 | 1577 | 0.020 |
Why?
|
| Genetic Markers | 1 | 2012 | 2608 | 0.020 |
Why?
|
| Pleural Neoplasms | 1 | 1991 | 609 | 0.020 |
Why?
|
| Immunotherapy | 2 | 2018 | 4642 | 0.020 |
Why?
|
| Proteome | 1 | 2016 | 1855 | 0.020 |
Why?
|
| Mutagenicity Tests | 1 | 2005 | 46 | 0.020 |
Why?
|
| Carcinogenicity Tests | 1 | 2005 | 38 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2015 | 2566 | 0.020 |
Why?
|
| Quality of Life | 2 | 2020 | 13308 | 0.020 |
Why?
|
| Cytotoxicity, Immunologic | 2 | 1981 | 1351 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2018 | 3616 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2015 | 3215 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2010 | 1636 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2012 | 2698 | 0.020 |
Why?
|
| Bone Marrow Transplantation | 1 | 2013 | 2693 | 0.020 |
Why?
|
| Nitric Oxide | 1 | 2014 | 2141 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2020 | 6381 | 0.020 |
Why?
|
| Heart Diseases | 3 | 1994 | 2809 | 0.020 |
Why?
|
| Hematologic Diseases | 1 | 1989 | 496 | 0.020 |
Why?
|
| Pulmonary Veins | 1 | 1991 | 745 | 0.020 |
Why?
|
| Lead | 1 | 2011 | 880 | 0.020 |
Why?
|
| Heart Rate | 4 | 2001 | 4179 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 1 | 2012 | 1612 | 0.020 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2011 | 812 | 0.020 |
Why?
|
| Acetates | 1 | 1986 | 321 | 0.020 |
Why?
|
| Computers, Molecular | 1 | 2004 | 14 | 0.020 |
Why?
|
| Mesothelioma | 1 | 1991 | 807 | 0.020 |
Why?
|
| Fertilizers | 1 | 2004 | 24 | 0.020 |
Why?
|
| Aneurysm | 1 | 1988 | 337 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2013 | 4122 | 0.010 |
Why?
|
| Comorbidity | 1 | 2019 | 10551 | 0.010 |
Why?
|
| Fixatives | 1 | 2004 | 91 | 0.010 |
Why?
|
| Sirolimus | 1 | 2011 | 1547 | 0.010 |
Why?
|
| Heart Neoplasms | 1 | 1988 | 360 | 0.010 |
Why?
|
| Decision Making | 1 | 1998 | 3925 | 0.010 |
Why?
|
| Pneumonectomy | 1 | 1991 | 1111 | 0.010 |
Why?
|
| HLA Antigens | 1 | 1990 | 1368 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2015 | 4357 | 0.010 |
Why?
|
| Macrophages | 2 | 2014 | 5745 | 0.010 |
Why?
|
| Oscillometry | 1 | 2004 | 145 | 0.010 |
Why?
|
| Graft Occlusion, Vascular | 1 | 1988 | 560 | 0.010 |
Why?
|
| Intestinal Diseases | 1 | 1989 | 506 | 0.010 |
Why?
|
| Protective Devices | 1 | 2004 | 72 | 0.010 |
Why?
|
| Hodgkin Disease | 1 | 1992 | 1378 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2014 | 2873 | 0.010 |
Why?
|
| Liver | 1 | 2019 | 7509 | 0.010 |
Why?
|
| Connecticut | 1 | 1984 | 365 | 0.010 |
Why?
|
| Coronary Angiography | 2 | 1994 | 4563 | 0.010 |
Why?
|
| Strontium Radioisotopes | 1 | 1983 | 18 | 0.010 |
Why?
|
| Adenocarcinoma | 2 | 1978 | 6315 | 0.010 |
Why?
|
| Piperazines | 1 | 2014 | 2525 | 0.010 |
Why?
|
| Electronics | 1 | 2004 | 315 | 0.010 |
Why?
|
| Disinfectants | 1 | 2004 | 130 | 0.010 |
Why?
|
| Cortisone | 1 | 1983 | 87 | 0.010 |
Why?
|
| Work Schedule Tolerance | 1 | 2006 | 551 | 0.010 |
Why?
|
| Pulmonary Artery | 1 | 1991 | 1921 | 0.010 |
Why?
|
| Morbidity | 2 | 1999 | 1765 | 0.010 |
Why?
|
| Biological Transport | 1 | 2007 | 2086 | 0.010 |
Why?
|
| Whole-Body Irradiation | 1 | 1983 | 433 | 0.010 |
Why?
|
| Ireland | 1 | 2002 | 172 | 0.010 |
Why?
|
| Dobutamine | 1 | 1982 | 116 | 0.010 |
Why?
|
| Carcinoma, Ehrlich Tumor | 1 | 1981 | 23 | 0.010 |
Why?
|
| Eating | 1 | 1988 | 1539 | 0.010 |
Why?
|
| Pancreas | 1 | 1988 | 1677 | 0.010 |
Why?
|
| Textile Industry | 1 | 2001 | 74 | 0.010 |
Why?
|
| Cost Savings | 1 | 2007 | 920 | 0.010 |
Why?
|
| Leukemia, Erythroblastic, Acute | 1 | 1981 | 176 | 0.010 |
Why?
|
| Atrial Fibrillation | 2 | 1998 | 5209 | 0.010 |
Why?
|
| Prognosis | 3 | 2012 | 29658 | 0.010 |
Why?
|
| tau Proteins | 1 | 2011 | 2085 | 0.010 |
Why?
|
| Coronary Vessels | 1 | 1972 | 3112 | 0.010 |
Why?
|
| Aortic Valve Insufficiency | 2 | 1982 | 584 | 0.010 |
Why?
|
| Vietnam | 1 | 2001 | 411 | 0.010 |
Why?
|
| Catecholamines | 1 | 1982 | 385 | 0.010 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2002 | 763 | 0.010 |
Why?
|
| DNA, Ribosomal | 1 | 2002 | 285 | 0.010 |
Why?
|
| Electronic Health Records | 1 | 2018 | 4775 | 0.010 |
Why?
|
| Gastrointestinal Diseases | 1 | 1989 | 1190 | 0.010 |
Why?
|
| Warfarin | 1 | 1989 | 1518 | 0.010 |
Why?
|
| Workload | 1 | 2006 | 847 | 0.010 |
Why?
|
| Power Plants | 1 | 1981 | 123 | 0.010 |
Why?
|
| Meta-Analysis as Topic | 1 | 2005 | 1376 | 0.010 |
Why?
|
| Documentation | 1 | 2007 | 893 | 0.010 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2012 | 2496 | 0.010 |
Why?
|
| Middle Cerebral Artery | 1 | 2001 | 276 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 2001 | 1316 | 0.010 |
Why?
|
| Survivors | 1 | 2010 | 2375 | 0.010 |
Why?
|
| Thrombosis | 1 | 1994 | 3052 | 0.010 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 1992 | 2159 | 0.010 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 1 | 2001 | 281 | 0.010 |
Why?
|
| Swine | 1 | 1989 | 5899 | 0.010 |
Why?
|
| Streptococcal Infections | 2 | 1994 | 617 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 1970 | 3486 | 0.010 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 1994 | 3986 | 0.010 |
Why?
|
| Cerebrovascular Disorders | 2 | 1998 | 1501 | 0.010 |
Why?
|
| Immunization | 2 | 1973 | 1227 | 0.010 |
Why?
|
| HIV Infections | 1 | 2005 | 17165 | 0.010 |
Why?
|
| Socioeconomic Factors | 2 | 2011 | 7806 | 0.010 |
Why?
|
| Antibodies | 2 | 1981 | 2421 | 0.010 |
Why?
|
| Health Services Needs and Demand | 1 | 2006 | 1399 | 0.010 |
Why?
|
| Brain | 3 | 2014 | 26951 | 0.010 |
Why?
|
| Rauscher Virus | 1 | 1978 | 13 | 0.010 |
Why?
|
| Partial Pressure | 1 | 1998 | 245 | 0.010 |
Why?
|
| Neoplasms, Experimental | 2 | 1973 | 1229 | 0.010 |
Why?
|
| Moloney murine leukemia virus | 1 | 1978 | 109 | 0.010 |
Why?
|
| AKR murine leukemia virus | 1 | 1977 | 3 | 0.010 |
Why?
|
| Respiratory Protective Devices | 1 | 1998 | 47 | 0.010 |
Why?
|
| Immunosorbent Techniques | 1 | 1977 | 176 | 0.010 |
Why?
|
| Multivariate Analysis | 3 | 1996 | 12159 | 0.010 |
Why?
|
| Particle Size | 1 | 2001 | 1644 | 0.010 |
Why?
|
| Illinois | 1 | 1997 | 118 | 0.010 |
Why?
|
| Antibodies, Heterophile | 1 | 1977 | 128 | 0.010 |
Why?
|
| Cyclophosphamide | 1 | 1983 | 2221 | 0.010 |
Why?
|
| Rabbits | 2 | 1973 | 4773 | 0.010 |
Why?
|
| Ventricular Function | 1 | 1998 | 408 | 0.010 |
Why?
|
| Lymphocytes | 2 | 1978 | 2611 | 0.010 |
Why?
|
| Hypertension, Pulmonary | 1 | 1987 | 1570 | 0.010 |
Why?
|
| Combined Modality Therapy | 3 | 1994 | 8552 | 0.010 |
Why?
|
| Likelihood Functions | 1 | 1999 | 987 | 0.010 |
Why?
|
| Pulmonary Gas Exchange | 1 | 1998 | 378 | 0.010 |
Why?
|
| Postoperative Care | 2 | 1996 | 1479 | 0.010 |
Why?
|
| Plasma Substitutes | 1 | 1976 | 57 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 1977 | 1142 | 0.010 |
Why?
|
| Clavicle | 1 | 1997 | 224 | 0.010 |
Why?
|
| Wrist | 1 | 1996 | 219 | 0.010 |
Why?
|
| Postoperative Hemorrhage | 1 | 1998 | 422 | 0.010 |
Why?
|
| Capsid | 1 | 1977 | 434 | 0.010 |
Why?
|
| Dopamine | 1 | 1982 | 1595 | 0.010 |
Why?
|
| Creatine Kinase | 1 | 1996 | 691 | 0.010 |
Why?
|
| Angina Pectoris | 1 | 1978 | 969 | 0.010 |
Why?
|
| Peripheral Vascular Diseases | 1 | 1997 | 515 | 0.010 |
Why?
|
| Range of Motion, Articular | 1 | 2001 | 1583 | 0.010 |
Why?
|
| Embolism | 1 | 1997 | 408 | 0.010 |
Why?
|
| Equipment Failure | 2 | 1989 | 577 | 0.010 |
Why?
|
| Catheterization, Peripheral | 1 | 1997 | 345 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 1989 | 12965 | 0.010 |
Why?
|
| Postoperative Period | 1 | 1998 | 1818 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2001 | 21025 | 0.010 |
Why?
|
| Cardiovascular Diseases | 2 | 2009 | 15757 | 0.010 |
Why?
|
| Prosthesis Failure | 1 | 1998 | 1206 | 0.010 |
Why?
|
| Hyaluronoglucosaminidase | 1 | 1973 | 135 | 0.010 |
Why?
|
| Fetal Proteins | 1 | 1973 | 97 | 0.010 |
Why?
|
| Curriculum | 1 | 2006 | 3718 | 0.010 |
Why?
|
| Immune Sera | 1 | 1973 | 613 | 0.010 |
Why?
|
| Neuraminidase | 1 | 1973 | 200 | 0.010 |
Why?
|
| Edetic Acid | 1 | 1973 | 282 | 0.010 |
Why?
|
| Trypsin | 1 | 1973 | 496 | 0.010 |
Why?
|
| Sex Distribution | 1 | 1998 | 2295 | 0.010 |
Why?
|
| Life Tables | 1 | 1992 | 365 | 0.010 |
Why?
|
| Xenon | 1 | 1972 | 112 | 0.010 |
Why?
|
| Thoracotomy | 1 | 1994 | 363 | 0.010 |
Why?
|
| Stroke Volume | 2 | 1998 | 5523 | 0.010 |
Why?
|
| Thrombocytopenia | 1 | 1980 | 1174 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2013 | 17790 | 0.010 |
Why?
|
| Blood Pressure | 2 | 2001 | 8525 | 0.010 |
Why?
|
| Hospital Mortality | 2 | 1998 | 5425 | 0.010 |
Why?
|
| Age Distribution | 1 | 1998 | 2893 | 0.010 |
Why?
|
| Isoenzymes | 1 | 1996 | 1690 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1988 | 8950 | 0.010 |
Why?
|
| Dinitrophenols | 1 | 1970 | 56 | 0.010 |
Why?
|
| Nutritional Status | 1 | 1999 | 1607 | 0.010 |
Why?
|
| Hand | 1 | 1996 | 903 | 0.010 |
Why?
|
| Hemagglutination Inhibition Tests | 1 | 1970 | 86 | 0.010 |
Why?
|
| Radioisotopes | 1 | 1972 | 495 | 0.010 |
Why?
|
| gamma-Globulins | 1 | 1970 | 123 | 0.010 |
Why?
|
| Myocardial Contraction | 1 | 1996 | 1516 | 0.010 |
Why?
|
| Wales | 1 | 1971 | 86 | 0.010 |
Why?
|
| Demography | 2 | 1989 | 1650 | 0.010 |
Why?
|
| Isoantigens | 1 | 1973 | 552 | 0.010 |
Why?
|
| Haptens | 1 | 1970 | 163 | 0.010 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 1997 | 698 | 0.010 |
Why?
|
| Tissue Extracts | 1 | 1970 | 140 | 0.010 |
Why?
|
| Population Density | 1 | 1971 | 192 | 0.010 |
Why?
|
| Whooping Cough | 1 | 1971 | 85 | 0.010 |
Why?
|
| Culture Techniques | 1 | 1970 | 530 | 0.010 |
Why?
|
| Serum Albumin, Bovine | 1 | 1970 | 323 | 0.010 |
Why?
|
| Rosette Formation | 2 | 1981 | 152 | 0.010 |
Why?
|
| Carbon Isotopes | 1 | 1970 | 459 | 0.010 |
Why?
|
| Emergencies | 1 | 1996 | 1211 | 0.010 |
Why?
|
| Accidents | 1 | 1971 | 166 | 0.010 |
Why?
|
| Pleura | 1 | 1991 | 244 | 0.010 |
Why?
|
| Crowding | 1 | 1971 | 142 | 0.010 |
Why?
|
| Diaphragm | 1 | 1991 | 351 | 0.010 |
Why?
|
| HLA-A Antigens | 1 | 1990 | 225 | 0.010 |
Why?
|
| Decision Support Techniques | 1 | 1999 | 2001 | 0.010 |
Why?
|
| Cyclosporine | 1 | 1992 | 777 | 0.010 |
Why?
|
| Computers | 1 | 1972 | 595 | 0.010 |
Why?
|
| Radiography | 2 | 1992 | 6965 | 0.010 |
Why?
|
| Ear Diseases | 1 | 1971 | 177 | 0.010 |
Why?
|
| Lectins | 1 | 1970 | 484 | 0.000 |
Why?
|
| Antibody Specificity | 1 | 1970 | 1060 | 0.000 |
Why?
|
| HLA-B Antigens | 1 | 1990 | 331 | 0.000 |
Why?
|
| Culture Media | 1 | 1970 | 900 | 0.000 |
Why?
|
| Estrus | 1 | 1988 | 70 | 0.000 |
Why?
|
| Methylprednisolone | 1 | 1990 | 384 | 0.000 |
Why?
|
| Paralysis | 1 | 1990 | 251 | 0.000 |
Why?
|
| Antilymphocyte Serum | 1 | 1990 | 482 | 0.000 |
Why?
|
| HLA-DR Antigens | 1 | 1990 | 630 | 0.000 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 1998 | 1582 | 0.000 |
Why?
|
| Transplantation, Homologous | 2 | 1992 | 4810 | 0.000 |
Why?
|
| Education | 1 | 1971 | 534 | 0.000 |
Why?
|
| Perfusion | 1 | 1972 | 1376 | 0.000 |
Why?
|
| Veterans | 1 | 2001 | 2642 | 0.000 |
Why?
|
| Immunoglobulins | 1 | 1970 | 859 | 0.000 |
Why?
|
| Hemolysis | 1 | 1989 | 423 | 0.000 |
Why?
|
| Intraoperative Period | 1 | 1988 | 516 | 0.000 |
Why?
|
| Angiography | 1 | 1972 | 1605 | 0.000 |
Why?
|
| Arteries | 1 | 1992 | 1126 | 0.000 |
Why?
|
| Echocardiography, Doppler | 1 | 1991 | 901 | 0.000 |
Why?
|
| Pericardium | 1 | 1991 | 675 | 0.000 |
Why?
|
| Immunologic Memory | 1 | 1973 | 1354 | 0.000 |
Why?
|
| Laparotomy | 1 | 1989 | 465 | 0.000 |
Why?
|
| Kidney Neoplasms | 2 | 1973 | 4312 | 0.000 |
Why?
|
| Congenital Abnormalities | 1 | 1971 | 704 | 0.000 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 1996 | 2128 | 0.000 |
Why?
|
| Antigens, Neoplasm | 1 | 1973 | 1998 | 0.000 |
Why?
|
| Predictive Value of Tests | 1 | 2001 | 15289 | 0.000 |
Why?
|
| Saphenous Vein | 1 | 1988 | 537 | 0.000 |
Why?
|
| Monitoring, Physiologic | 1 | 1972 | 1784 | 0.000 |
Why?
|
| Spermatozoa | 1 | 1988 | 631 | 0.000 |
Why?
|
| Heart Failure | 1 | 1987 | 11847 | 0.000 |
Why?
|
| Electrocardiography | 1 | 1996 | 6414 | 0.000 |
Why?
|
| Anticoagulants | 1 | 1998 | 4897 | 0.000 |
Why?
|
| Arrhythmias, Cardiac | 1 | 1992 | 2255 | 0.000 |
Why?
|
| Length of Stay | 1 | 1996 | 6479 | 0.000 |
Why?
|
| Stimulation, Chemical | 1 | 1982 | 306 | 0.000 |
Why?
|
| Social Class | 1 | 1971 | 2005 | 0.000 |
Why?
|
| Graft Survival | 1 | 1992 | 3794 | 0.000 |
Why?
|
| Binding Sites, Antibody | 1 | 1981 | 337 | 0.000 |
Why?
|
| Ascitic Fluid | 1 | 1981 | 189 | 0.000 |
Why?
|
| Adipose Tissue | 1 | 1972 | 3301 | 0.000 |
Why?
|
| Myocardium | 1 | 1972 | 4700 | 0.000 |
Why?
|
| Influenza, Human | 1 | 1971 | 1528 | 0.000 |
Why?
|
| Ultrasonography | 1 | 1992 | 5961 | 0.000 |
Why?
|
| Multiple Myeloma | 1 | 1997 | 5130 | 0.000 |
Why?
|
| Pneumonia | 1 | 1971 | 2131 | 0.000 |
Why?
|
| Preoperative Care | 1 | 1988 | 2256 | 0.000 |
Why?
|
| Intensive Care Units | 1 | 1972 | 3736 | 0.000 |
Why?
|
| Tuberculosis | 1 | 1971 | 2001 | 0.000 |
Why?
|
| Obesity | 1 | 1999 | 12922 | 0.000 |
Why?
|
| Hemorrhage | 1 | 1989 | 3600 | 0.000 |
Why?
|
| Electroencephalography | 1 | 1992 | 6189 | 0.000 |
Why?
|
| Life Expectancy | 1 | 1981 | 1248 | 0.000 |
Why?
|
| Antibodies, Monoclonal | 1 | 1990 | 9185 | 0.000 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 1991 | 11712 | 0.000 |
Why?
|
| Immunoglobulin G | 1 | 1978 | 4541 | 0.000 |
Why?
|